Market Research Logo

Neurodegenerative Disorders Drug Development Pipeline Review, 2017

Neurodegenerative Disorders Drug Development Pipeline Review, 2017

Summary


Neurodegenerative disorders are a cluster of conditions that affect the central nervous system. They include both hereditary and sporadic conditions that are characterized by slow, irreversible, progressive dysfunction of the nervous system with the increasing degeneration of neurons, which causes symptoms such as motor impairment, memory loss and declining cognitive ability. Neurodegenerative disorders cannot currently be cured, and treatment is aimed at managing the disease indication in order to reduce the severity of symptoms and slow progression.

There are over 1,400 products in active development in the neurodegenerative disorders therapy area. The current market landscape consists of a number of biologics and small molecules, while the pipeline also consists of gene therapies and cell therapies, demonstrating broader pharmaceutical research and development.

Small molecule drugs dominate the pipeline, with approximately 64% of total pipeline molecules. In comparison, the number of biologics in the pipeline is much lower, representing approximately 26% of the pipeline. Overall the neurodegenerative disorders pipeline is large, with a substantial proportion of products being early-stage assets at the Preclinical development stage.

The report provides comprehensive information on the pipeline development landscape for is Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Amyotrophic lateral sclerosis and Multiple sclerosis, from Discovery through to the Pre-registration stage. This includes an analysis of products by stage of development, molecular target, mechanism of action (MoA), route of administration (RoA) and molecule type. Finally, the report provides an overview of key players involved in the development of products in this area, and outlines recent updates and press releases in the field.

Scope

  • Which companies are the most active within the pipeline for neurodegenerative disorders?
  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have happened in this disease area?
Reasons to buy
  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration


  • GBI Research Report Guidance
  • Executive Summary
  • Introduction
    • Neurodegenerative Disorders Report Coverage
    • Alzheimer's Disease Overview
    • Amyotrophic Lateral Sclerosis Overview
    • Huntington Disease Overview
    • Multiple Sclerosis Overview
    • Parkinson's Disease Overview
  • Therapeutics Development
    • Alzheimer's Disease
      • Pipeline Products for Alzheimer's Disease - Overview
        • Table Figure 1: Number of Products under Development for Alzheimer's Disease
        • Table Number of Products under Development for Alzheimer's Disease
      • Pipeline Products for Alzheimer's Disease - Comparative Analysis
        • Table Figure 2: Number of Products under Development for Alzheimer's Disease - Comparative Analysis
        • Table Number of Products under Development for Alzheimer's Disease - Comparative Analysis
    • Amyotrophic Lateral Sclerosis
      • Pipeline Products for Amyotrophic Lateral Sclerosis - Overview
        • Table Figure 3: Number of Products under Development for Amyotrophic Lateral Sclerosis
        • Table Number of Products under Development for Amyotrophic Lateral Sclerosis
      • Pipeline Products for Amyotrophic Lateral Sclerosis - Comparative Analysis
        • Table Figure 4: Number of Products under Development for Amyotrophic Lateral Sclerosis - Comparative Analysis
        • Table Number of Products under Development for Amyotrophic Lateral Sclerosis - Comparative Analysis
    • Huntington Disease
      • Pipeline Products for Huntington Disease - Overview
        • Table Figure 5: Number of Products under Development for Huntington Disease
        • Table Number of Products under Development for Huntington Disease
      • Pipeline Products for Huntington Disease - Comparative Analysis
        • Table Figure 6: Number of Products under Development for Huntington Disease - Comparative Analysis
        • Table Number of Products under Development for Huntington Disease - Comparative Analysis
    • Multiple Sclerosis
      • Pipeline Products for Multiple Sclerosis - Overview
        • Table Figure 7: Number of Products under Development for Multiple Sclerosis
        • Table Number of Products under Development for Multiple Sclerosis
      • Pipeline Products for Multiple Sclerosis - Comparative Analysis
        • Table Figure 8: Number of Products under Development for Multiple Sclerosis - Comparative Analysis
        • Table Number of Products under Development for Multiple Sclerosis - Comparative Analysis
    • Parkinson's Disease
      • Pipeline Products for Parkinson's Disease - Overview
        • Table Figure 9: Number of Products under Development for Parkinson's Disease
        • Table Number of Products under Development for Parkinson's Disease
      • Pipeline Products for Parkinson's Disease - Comparative Analysis
        • Table Figure 10: Number of Products under Development for Parkinson's Disease - Comparative Analysis
        • Table Number of Products under Development for Parkinson's Disease - Comparative Analysis
  • Therapeutics under Development by Companies
    • Alzheimer's Disease
      • Table Figure 11: Number of Products under Development by Companies, Alzheimer's Disease
      • Table Number of Products under Development by Companies, Alzheimer's Disease
    • Amyotrophic Lateral Sclerosis
      • Table Figure 12: Number of Products under Development by Companies, Amyotrophic Lateral Sclerosis
      • Table Number of Products under Development by Companies, Amyotrophic Lateral Sclerosis
    • Huntington Disease
      • Table Figure 13: Number of Products under Development by Companies, Huntington Disease
      • Table Number of Products under Development by Companies, Huntington Disease
    • Multiple Sclerosis
      • Table Figure 14: Number of Products under Development by Companies, Multiple Sclerosis
      • Table Number of Products under Development by Companies, Multiple Sclerosis
    • Parkinson's Disease
      • Table Figure 15: Number of Products under Development by Companies, Parkinson's Disease
      • Table Number of Products under Development by Companies, Parkinson's Disease
  • Therapeutics under Investigation by Universities/Institutes
    • Alzheimer's Disease
      • Table Figure 16: Number of Products under Investigation by Universities/Institutes, Alzheimer's Disease
      • Table Number of Products under Investigation by Universities/Institutes, Alzheimer's Disease
    • Amyotrophic Lateral Sclerosis
      • Table Figure 17: Number of Products under Investigation by Universities/Institutes, Amyotrophic Lateral Sclerosis
      • Table Number of Products under Investigation by Universities/Institutes, Amyotrophic Lateral Sclerosis
    • Huntington Disease
      • Table Figure 18: Number of Products under Investigation by Universities/Institutes, Huntington Disease
      • Table Number of Products under Investigation by Universities/Institutes, Huntington Disease
    • Multiple Sclerosis
      • Table Figure 19: Number of Products under Investigation by Universities/Institutes, Multiple Sclerosis
      • Table Number of Products under Investigation by Universities/Institutes, Multiple Sclerosis
    • Parkinson's Disease
      • Table Figure 20: Number of Products under Investigation by Universities/Institutes, Parkinson's Disease
      • Table Number of Products under Investigation by Universities/Institutes, Parkinson's Disease
  • Pipeline Products Glance
    • Alzheimer's Disease
      • Late Stage Products
        • Table Figure 21: Comparative Analysis by Late Stage Development, Alzheimer's Disease
        • Table Comparative Analysis by Late Stage Development, Alzheimer's Disease
      • Clinical Stage Products
        • Table Figure 22: Comparative Analysis by Clinical Stage Development, Alzheimer's Disease
        • Table Comparative Analysis by Clinical Stage Development, Alzheimer's Disease
      • Early Stage Products
        • Table Figure 23: Comparative Analysis by Early Stage Products, Alzheimer's Disease
        • Table Comparative Analysis by Early Stage Development, Alzheimer's Disease
      • Unknown Stage Products
        • Table Comparative Analysis by Unknown Stage Development, Alzheimer's Disease
    • Amyotrophic Lateral Sclerosis
      • Late Stage Products
        • Table Figure 24: Comparative Analysis by Late Stage Development, Amyotrophic Lateral Sclerosis
        • Table Comparative Analysis by Late Stage Development, Amyotrophic Lateral Sclerosis
      • Clinical Stage Products
        • Table Figure 25: Comparative Analysis by Clinical Stage Development, Amyotrophic Lateral Sclerosis
        • Table Comparative Analysis by Clinical Stage Development, Amyotrophic Lateral Sclerosis
      • Early Stage Products
        • Table Figure 26: Comparative Analysis by Early Stage Products, Amyotrophic Lateral Sclerosis
        • Table Comparative Analysis by Early Stage Development, Amyotrophic Lateral Sclerosis
      • Unknown Stage Products
        • Table Comparative Analysis by Unknown Stage Development, Amyotrophic Lateral Sclerosis
    • Huntington Disease
      • Late Stage Products
        • Table Figure 27: Comparative Analysis by Late Stage Development, Huntington Disease
        • Table Comparative Analysis by Late Stage Development, Huntington Disease
      • Clinical Stage Products
        • Table Figure 28: Comparative Analysis by Clinical Stage Development, Huntington Disease
        • Table Comparative Analysis by Clinical Stage Development, Huntington Disease
      • Early Stage Products
        • Table Figure 29: Comparative Analysis by Early Stage Products, Huntington Disease
        • Table Comparative Analysis by Early Stage Development, Huntington Disease
    • Multiple Sclerosis
      • Late Stage Products
        • Table Figure 30: Comparative Analysis by Late Stage Development, Multiple Sclerosis
        • Table Comparative Analysis by Late Stage Development, Multiple Sclerosis
      • Clinical Stage Products
        • Table Figure 31: Comparative Analysis by Clinical Stage Development, Multiple Sclerosis
        • Table Comparative Analysis by Clinical Stage Development, Multiple Sclerosis
      • Early Stage Products
        • Table Figure 32: Comparative Analysis by Early Stage Products, Multiple Sclerosis
        • Table Comparative Analysis by Early Stage Development, Multiple Sclerosis
      • Unknown Stage Products
        • Table Comparative Analysis by Unknown Stage Development, Multiple Sclerosis
    • Parkinson's Disease
      • Late Stage Products
        • Table Figure 33: Comparative Analysis by Late Stage Development, Parkinson's Disease
        • Table Comparative Analysis by Late Stage Development, Parkinson's Disease
      • Clinical Stage Products
        • Table Figure 34: Comparative Analysis by Clinical Stage Development, Parkinson's Disease
        • Table Comparative Analysis by Clinical Stage Development, Parkinson's Disease
      • Early Stage Products
        • Table Figure 35: Comparative Analysis by Early Stage Products, Parkinson's Disease
        • Table Comparative Analysis by Early Stage Development, Parkinson's Disease
      • Unknown Stage Products
        • Table Figure 36: Comparative Analysis by Unknown Stage Development, Parkinson's Disease
        • Table Comparative Analysis by Unknown Stage Development, Parkinson's Disease
  • Products under Development by Companies
    • Alzheimer's Disease
      • Table Products under Development by Companies, Alzheimer's Disease
    • Amyotrophic Lateral Sclerosis
      • Table Products under Development by Companies, Amyotrophic Lateral Sclerosis
    • Huntington Disease
      • Table Products under Development by Companies, Huntington Disease
    • Multiple Sclerosis
      • Table Products under Development by Companies, Multiple Sclerosis
    • Parkinson's Disease
      • Table Products under Development by Companies, Parkinson's Disease
  • Products under Investigation by Universities/Institutes
    • Alzheimer's Disease
      • Table Products under Investigation by Universities/Institutes, Alzheimer's Disease
    • Amyotrophic Lateral Sclerosis
      • Table Products under Investigation by Universities/Institutes, Amyotrophic Lateral Sclerosis
    • Huntington Disease
      • Table Products under Investigation by Universities/Institutes, Huntington Disease
    • Multiple Sclerosis
      • Table Products under Investigation by Universities/Institutes, Multiple Sclerosis
    • Parkinson's Disease
      • Table Products under Investigation by Universities/Institutes, Parkinson's Disease
  • Companies Involved in Therapeutics Development
    • Alzheimer's Disease
      • AB Science SA
        • Table Alzheimer's Disease - Pipeline by AB Science SA,
      • AbbVie Inc
        • Table Alzheimer's Disease - Pipeline by AbbVie Inc,
      • AC Immune SA
        • Table Alzheimer's Disease - Pipeline by AC Immune SA,
      • Accera, Inc.
        • Table Alzheimer's Disease - Pipeline by Accera, Inc.,
      • Acelot, Inc.
        • Table Alzheimer's Disease - Pipeline by Acelot, Inc.,
      • Actinogen Limited
        • Table Alzheimer's Disease - Pipeline by Actinogen Limited,
      • Acumen Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by Acumen Pharmaceuticals, Inc.,
      • Addex Therapeutics Ltd
        • Table Alzheimer's Disease - Pipeline by Addex Therapeutics Ltd,
      • Affibody AB
        • Table Alzheimer's Disease - Pipeline by Affibody AB,
      • AFFiRiS AG
        • Table Alzheimer's Disease - Pipeline by AFFiRiS AG,
      • Alector LLC
        • Table Alzheimer's Disease - Pipeline by Alector LLC,
      • Alkermes Plc
        • Table Alzheimer's Disease - Pipeline by Alkermes Plc,
      • Allergan Plc
        • Table Alzheimer's Disease - Pipeline by Allergan Plc,
      • Allinky Biopharma
        • Table Alzheimer's Disease - Pipeline by Allinky Biopharma,
      • ALSP, Inc.
        • Table Alzheimer's Disease - Pipeline by ALSP, Inc.,
      • Alzhyme Pty Ltd
        • Table Alzheimer's Disease - Pipeline by Alzhyme Pty Ltd,
      • Alzinova AB
        • Table Alzheimer's Disease - Pipeline by Alzinova AB,
      • AlzProtect SAS
        • Table Alzheimer's Disease - Pipeline by AlzProtect SAS,
      • Amarantus Bioscience Holdings, Inc.
        • Table Alzheimer's Disease - Pipeline by Amarantus Bioscience Holdings, Inc.,
      • Amgen Inc.
        • Table Alzheimer's Disease - Pipeline by Amgen Inc.,
      • Anavex Life Sciences Corp.
        • Table Alzheimer's Disease - Pipeline by Anavex Life Sciences Corp.,
      • Aphios Corporation
        • Table Alzheimer's Disease - Pipeline by Aphios Corporation,
      • Apodemus AB
        • Table Alzheimer's Disease - Pipeline by Apodemus AB,
      • Applied Research using OMIC Sciences, S.L.
        • Table Alzheimer's Disease - Pipeline by Applied Research using OMIC Sciences, S.L.,
      • Araclon Biotech, S.L.
        • Table Alzheimer's Disease - Pipeline by Araclon Biotech, S.L.,
      • Archer Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by Archer Pharmaceuticals, Inc.,
      • ArmaGen Inc.
        • Table Alzheimer's Disease - Pipeline by ArmaGen Inc.,
      • Artery Therapeutics, Inc.
        • Table Alzheimer's Disease - Pipeline by Artery Therapeutics, Inc.,
      • AskAt Inc.
        • Table Alzheimer's Disease - Pipeline by AskAt Inc.,
      • Astellas Pharma Inc.
        • Table Alzheimer's Disease - Pipeline by Astellas Pharma Inc.,
      • AstraZeneca Plc
        • Table Alzheimer's Disease - Pipeline by AstraZeneca Plc,
      • Asubio Pharma Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by Asubio Pharma Co., Ltd.,
      • Ausio Pharmaceuticals, LLC
        • Table Alzheimer's Disease - Pipeline by Ausio Pharmaceuticals, LLC,
      • Avineuro Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by Avineuro Pharmaceuticals, Inc.,
      • Axon Neuroscience SE
        • Table Alzheimer's Disease - Pipeline by Axon Neuroscience SE,
      • Axovant Sciences Ltd.
        • Table Alzheimer's Disease - Pipeline by Axovant Sciences Ltd.,
      • Axsome Therapeutics, Inc.
        • Table Alzheimer's Disease - Pipeline by Axsome Therapeutics, Inc.,
      • Axxam SpA
        • Table Alzheimer's Disease - Pipeline by Axxam SpA,
      • Beactica AB
        • Table Alzheimer's Disease - Pipeline by Beactica AB,
      • Berg LLC
        • Table Alzheimer's Disease - Pipeline by Berg LLC,
      • BioArctic Neuroscience AB
        • Table Alzheimer's Disease - Pipeline by BioArctic Neuroscience AB,
      • Bioasis Technologies Inc.
        • Table Alzheimer's Disease - Pipeline by Bioasis Technologies Inc.,
      • Biogen Inc
        • Table Alzheimer's Disease - Pipeline by Biogen Inc,
      • Biomar Microbial Technologies
        • Table Alzheimer's Disease - Pipeline by Biomar Microbial Technologies,
      • Bionature E.A. Ltd.
        • Table Alzheimer's Disease - Pipeline by Bionature E.A. Ltd.,
      • Boehringer Ingelheim GmbH
        • Table Alzheimer's Disease - Pipeline by Boehringer Ingelheim GmbH,
      • Bristol-Myers Squibb Company
        • Table Alzheimer's Disease - Pipeline by Bristol-Myers Squibb Company,
      • Bsim2
        • Table Alzheimer's Disease - Pipeline by Bsim2,
      • Cardax Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by Cardax Pharmaceuticals, Inc.,
      • Carna Biosciences, Inc.
        • Table Alzheimer's Disease - Pipeline by Carna Biosciences, Inc.,
      • Celon Pharma Sp. z o.o.
        • Table Alzheimer's Disease - Pipeline by Celon Pharma Sp. z o.o.,
      • CHA Bio & Diostech Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by CHA Bio & Diostech Co., Ltd.,
      • Chase Pharmaceuticals Corporation
        • Table Alzheimer's Disease - Pipeline by Chase Pharmaceuticals Corporation,
      • Clera Inc.
        • Table Alzheimer's Disease - Pipeline by Clera Inc.,
      • Cognition Therapeutics, Inc.
        • Table Alzheimer's Disease - Pipeline by Cognition Therapeutics, Inc.,
      • Cognosci, Inc.
        • Table Alzheimer's Disease - Pipeline by Cognosci, Inc.,
      • CohBar, Inc.
        • Table Alzheimer's Disease - Pipeline by CohBar, Inc.,
      • Connexios Life Sciences Pvt. Ltd.
        • Table Alzheimer's Disease - Pipeline by Connexios Life Sciences Pvt. Ltd.,
      • ContraVir Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by ContraVir Pharmaceuticals, Inc.,
      • Corium International, Inc.
        • Table Alzheimer's Disease - Pipeline by Corium International, Inc.,
      • Coronis Partners Ltd.
        • Table Alzheimer's Disease - Pipeline by Coronis Partners Ltd.,
      • Cortice Biosciences, Inc.
        • Table Alzheimer's Disease - Pipeline by Cortice Biosciences, Inc.,
      • Critical Outcome Technologies Inc.
        • Table Alzheimer's Disease - Pipeline by Critical Outcome Technologies Inc.,
      • Crossbeta Biosciences B.V.
        • Table Alzheimer's Disease - Pipeline by Crossbeta Biosciences B.V.,
      • D-Pharm Ltd.
        • Table Alzheimer's Disease - Pipeline by D-Pharm Ltd.,
      • Daewoong Pharmaceutical Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by Daewoong Pharmaceutical Co., Ltd.,
      • Daiichi Sankyo Company, Limited
        • Table Alzheimer's Disease - Pipeline by Daiichi Sankyo Company, Limited,
      • Daval International Limited
        • Table Alzheimer's Disease - Pipeline by Daval International Limited,
      • DermaXon, LLC
        • Table Alzheimer's Disease - Pipeline by DermaXon, LLC,
      • Dongkook Pharmaceutical Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by Dongkook Pharmaceutical Co., Ltd.,
      • Eisai Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by Eisai Co., Ltd.,
      • Eli Lilly and Company
        • Table Alzheimer's Disease - Pipeline by Eli Lilly and Company,
      • Emergent BioSolutions Inc.
        • Table Alzheimer's Disease - Pipeline by Emergent BioSolutions Inc.,
      • EncephRx, Inc.
        • Table Alzheimer's Disease - Pipeline by EncephRx, Inc.,
      • Endece, LLC
        • Table Alzheimer's Disease - Pipeline by Endece, LLC,
      • ENKAM Pharmaceuticals A/S
        • Table Alzheimer's Disease - Pipeline by ENKAM Pharmaceuticals A/S,
      • Ensemble Therapeutics Corporation
        • Table Alzheimer's Disease - Pipeline by Ensemble Therapeutics Corporation,
      • Ensol Biosciences Inc.
        • Table Alzheimer's Disease - Pipeline by Ensol Biosciences Inc.,
      • Epigen Biosciences, Inc.
        • Table Alzheimer's Disease - Pipeline by Epigen Biosciences, Inc.,
      • Euroscreen S.A.
        • Table Alzheimer's Disease - Pipeline by Euroscreen S.A.,
      • Evotec AG
        • Table Alzheimer's Disease - Pipeline by Evotec AG,
      • F. Hoffmann-La Roche Ltd.
        • Table Alzheimer's Disease - Pipeline by F. Hoffmann-La Roche Ltd.,
      • FORUM Pharmaceuticals Inc.
        • Table Alzheimer's Disease - Pipeline by FORUM Pharmaceuticals Inc.,
      • Genentech, Inc.
        • Table Alzheimer's Disease - Pipeline by Genentech, Inc.,
      • Genervon Biopharmaceuticals, LLC
        • Table Alzheimer's Disease - Pipeline by Genervon Biopharmaceuticals, LLC,
      • GlaxoSmithKline Plc
        • Table Alzheimer's Disease - Pipeline by GlaxoSmithKline Plc,
      • GliaCure Inc.
        • Table Alzheimer's Disease - Pipeline by GliaCure Inc.,
      • Glialogix, Inc.
        • Table Alzheimer's Disease - Pipeline by Glialogix, Inc.,
      • Golden Biotechnology Corp.
        • Table Alzheimer's Disease - Pipeline by Golden Biotechnology Corp.,
      • Grifols, S.A.
        • Table Alzheimer's Disease - Pipeline by Grifols, S.A.,
      • H. Lundbeck A/S
        • Table Alzheimer's Disease - Pipeline by H. Lundbeck A/S,
      • Heptares Therapeutics Limited
        • Table Alzheimer's Disease - Pipeline by Heptares Therapeutics Limited,
      • HitGen LTD
        • Table Alzheimer's Disease - Pipeline by HitGen LTD,
      • Humanetics Corporation
        • Table Alzheimer's Disease - Pipeline by Humanetics Corporation,
      • Ichor Medical Systems, Inc.
        • Table Alzheimer's Disease - Pipeline by Ichor Medical Systems, Inc.,
      • Icure Pharmaceutical Inc.
        • Table Alzheimer's Disease - Pipeline by Icure Pharmaceutical Inc.,
      • Immungenetics AG
        • Table Alzheimer's Disease - Pipeline by Immungenetics AG,
      • Impel NeuroPharma, Inc.
        • Table Alzheimer's Disease - Pipeline by Impel NeuroPharma, Inc.,
      • ImStar Therapeutics Inc.
        • Table Alzheimer's Disease - Pipeline by ImStar Therapeutics Inc.,
      • Inovio Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by Inovio Pharmaceuticals, Inc.,
      • IntelGenx Corp.
        • Table Alzheimer's Disease - Pipeline by IntelGenx Corp.,
      • Intellect Neurosciences, Inc.
        • Table Alzheimer's Disease - Pipeline by Intellect Neurosciences, Inc.,
      • Intra-Cellular Therapies, Inc.
        • Table Alzheimer's Disease - Pipeline by Intra-Cellular Therapies, Inc.,
      • INVENT Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by INVENT Pharmaceuticals, Inc.,
      • Io Therapeutics, Inc.
        • Table Alzheimer's Disease - Pipeline by Io Therapeutics, Inc.,
      • Iproteos S.L.
        • Table Alzheimer's Disease - Pipeline by Iproteos S.L.,
      • Jeil Pharmaceutical Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by Jeil Pharmaceutical Co., Ltd.,
      • Jiangsu Kanion Pharmaceutical Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by Jiangsu Kanion Pharmaceutical Co., Ltd.,
      • Johnson & Johnson
        • Table Alzheimer's Disease - Pipeline by Johnson & Johnson,
      • K-Stemcell Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by K-Stemcell Co., Ltd.,
      • Kadmon Corporation, LLC
        • Table Alzheimer's Disease - Pipeline by Kadmon Corporation, LLC,
      • Kalgene Pharmaceuticals Inc.
        • Table Alzheimer's Disease - Pipeline by Kalgene Pharmaceuticals Inc.,
      • Kareus Therapeutics, SA
        • Table Alzheimer's Disease - Pipeline by Kareus Therapeutics, SA,
      • KineMed, Inc.
        • Table Alzheimer's Disease - Pipeline by KineMed, Inc.,
      • Krenitsky Pharmaceuticals Inc.
        • Table Alzheimer's Disease - Pipeline by Krenitsky Pharmaceuticals Inc.,
      • Kyowa Hakko Kirin Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by Kyowa Hakko Kirin Co., Ltd.,
      • Lead Discovery Center GmbH
        • Table Alzheimer's Disease - Pipeline by Lead Discovery Center GmbH,
      • Les Laboratoires Servier SAS
        • Table Alzheimer's Disease - Pipeline by Les Laboratoires Servier SAS,
      • Lipopharma Therapeutics SL
        • Table Alzheimer's Disease - Pipeline by Lipopharma Therapeutics SL,
      • Living Cell Technologies Limited
        • Table Alzheimer's Disease - Pipeline by Living Cell Technologies Limited,
      • Lupin Limited
        • Table Alzheimer's Disease - Pipeline by Lupin Limited,
      • M3 Biotechnology, Inc.
        • Table Alzheimer's Disease - Pipeline by M3 Biotechnology, Inc.,
      • ManRos Therapeutics
        • Table Alzheimer's Disease - Pipeline by ManRos Therapeutics,
      • MedDay SA
        • Table Alzheimer's Disease - Pipeline by MedDay SA,
      • Medestea Research & Production S.p.A.
        • Table Alzheimer's Disease - Pipeline by Medestea Research & Production S.p.A.,
      • MedImmune, LLC
        • Table Alzheimer's Disease - Pipeline by MedImmune, LLC,
      • Medisyn Technologies, Inc.
        • Table Alzheimer's Disease - Pipeline by Medisyn Technologies, Inc.,
      • MEDRx Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by MEDRx Co., Ltd.,
      • Merck & Co., Inc.
        • Table Alzheimer's Disease - Pipeline by Merck & Co., Inc.,
      • Metabolic Solutions Development Company, LLC
        • Table Alzheimer's Disease - Pipeline by Metabolic Solutions Development Company, LLC,
      • Mithridion, Inc.
        • Table Alzheimer's Disease - Pipeline by Mithridion, Inc.,
      • Mitochon Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by Mitochon Pharmaceuticals, Inc.,
      • NAL Pharmaceuticals Ltd.
        • Table Alzheimer's Disease - Pipeline by NAL Pharmaceuticals Ltd.,
      • Nanomerics Ltd
        • Table Alzheimer's Disease - Pipeline by Nanomerics Ltd,
      • Nanotherapeutics, Inc.
        • Table Alzheimer's Disease - Pipeline by Nanotherapeutics, Inc.,
      • Neuralstem, Inc.
        • Table Alzheimer's Disease - Pipeline by Neuralstem, Inc.,
      • Neuraltus Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by Neuraltus Pharmaceuticals, Inc.,
      • Neurim Pharmaceuticals Ltd
        • Table Alzheimer's Disease - Pipeline by Neurim Pharmaceuticals Ltd,
      • Neuro-Sys SAS
        • Table Alzheimer's Disease - Pipeline by Neuro-Sys SAS ,
      • Neurodyn Inc.
        • Table Alzheimer's Disease - Pipeline by Neurodyn Inc.,
      • NeuroGeneration, Inc.
        • Table Alzheimer's Disease - Pipeline by NeuroGeneration, Inc.,
      • NeuroGenetic Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by NeuroGenetic Pharmaceuticals, Inc.,
      • NeuroNascent, Inc.
        • Table Alzheimer's Disease - Pipeline by NeuroNascent, Inc.,
      • Neuronax SAS
        • Table Alzheimer's Disease - Pipeline by Neuronax SAS,
      • NeurOp, Inc
        • Table Alzheimer's Disease - Pipeline by NeurOp, Inc,
      • NeuroPhage Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by NeuroPhage Pharmaceuticals, Inc.,
      • Neuropore Therapies, Inc.
        • Table Alzheimer's Disease - Pipeline by Neuropore Therapies, Inc.,
      • Neurotez, Inc.
        • Table Alzheimer's Disease - Pipeline by Neurotez, Inc.,
      • New World Laboratories, Inc.
        • Table Alzheimer's Disease - Pipeline by New World Laboratories, Inc.,
      • nLife Therapeutics, S.L.
        • Table Alzheimer's Disease - Pipeline by nLife Therapeutics, S.L.,
      • NLS Pharma Group
        • Table Alzheimer's Disease - Pipeline by NLS Pharma Group,
      • Novartis AG
        • Table Alzheimer's Disease - Pipeline by Novartis AG,
      • NsGene A/S
        • Table Alzheimer's Disease - Pipeline by NsGene A/S,
      • Oligomerix, inc.
        • Table Alzheimer's Disease - Pipeline by Oligomerix, inc.,
      • ORPHIT
        • Table Alzheimer's Disease - Pipeline by ORPHIT,
      • Oryzon Genomics SA
        • Table Alzheimer's Disease - Pipeline by Oryzon Genomics SA,
      • Otsuka Holdings Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by Otsuka Holdings Co., Ltd.,
      • P2D Bioscience
        • Table Alzheimer's Disease - Pipeline by P2D Bioscience,
      • Pain Therapeutics, Inc.
        • Table Alzheimer's Disease - Pipeline by Pain Therapeutics, Inc.,
      • Palumed S.A.
        • Table Alzheimer's Disease - Pipeline by Palumed S.A.,
      • Panacea Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by Panacea Pharmaceuticals, Inc.,
      • PeptiDream Inc.
        • Table Alzheimer's Disease - Pipeline by PeptiDream Inc.,
      • Peptron, Inc.
        • Table Alzheimer's Disease - Pipeline by Peptron, Inc.,
      • Pfizer Inc.
        • Table Alzheimer's Disease - Pipeline by Pfizer Inc.,
      • PharmaKure Limited
        • Table Alzheimer's Disease - Pipeline by PharmaKure Limited,
      • PharmatrophiX, Inc.
        • Table Alzheimer's Disease - Pipeline by PharmatrophiX, Inc.,
      • Pharmaxis Limited
        • Table Alzheimer's Disease - Pipeline by Pharmaxis Limited,
      • Pharnext SA
        • Table Alzheimer's Disease - Pipeline by Pharnext SA,
      • Phenomenome Discoveries, Inc.
        • Table Alzheimer's Disease - Pipeline by Phenomenome Discoveries, Inc.,
      • Pivot Pharmaceuticals Inc
        • Table Alzheimer's Disease - Pipeline by Pivot Pharmaceuticals Inc,
      • Prevacus, Inc.
        • Table Alzheimer's Disease - Pipeline by Prevacus, Inc.,
      • Probiodrug AG
        • Table Alzheimer's Disease - Pipeline by Probiodrug AG,
      • Progenra, Inc.
        • Table Alzheimer's Disease - Pipeline by Progenra, Inc.,
      • ProMIS Neurosciences Inc.
        • Table Alzheimer's Disease - Pipeline by ProMIS Neurosciences Inc.,
      • ProQR Therapeutics N.V.
        • Table Alzheimer's Disease - Pipeline by ProQR Therapeutics N.V.,
      • Proteome Sciences Plc
        • Table Alzheimer's Disease - Pipeline by Proteome Sciences Plc,
      • Proteostasis Therapeutics, Inc.
        • Table Alzheimer's Disease - Pipeline by Proteostasis Therapeutics, Inc.,
      • QR Pharma, Inc.
        • Table Alzheimer's Disease - Pipeline by QR Pharma, Inc.,
      • Radius Health, Inc.
        • Table Alzheimer's Disease - Pipeline by Radius Health, Inc.,
      • Regenera Pharma Ltd.
        • Table Alzheimer's Disease - Pipeline by Regenera Pharma Ltd.,
      • reMYND NV
        • Table Alzheimer's Disease - Pipeline by reMYND NV,
      • Resverlogix Corp.
        • Table Alzheimer's Disease - Pipeline by Resverlogix Corp.,
      • Retrotope, Inc
        • Table Alzheimer's Disease - Pipeline by Retrotope, Inc,
      • ReXceptor Inc.
        • Table Alzheimer's Disease - Pipeline by ReXceptor Inc.,
      • Rodos BioTarget GmbH
        • Table Alzheimer's Disease - Pipeline by Rodos BioTarget GmbH,
      • Sage Therapeutics, Inc.
        • Table Alzheimer's Disease - Pipeline by Sage Therapeutics, Inc.,
      • SanBio, Inc.
        • Table Alzheimer's Disease - Pipeline by SanBio, Inc.,
      • Saneron CCEL Therapeutics, Inc.
        • Table Alzheimer's Disease - Pipeline by Saneron CCEL Therapeutics, Inc.,
      • Saniona AB
        • Table Alzheimer's Disease - Pipeline by Saniona AB,
      • Sanofi
        • Table Alzheimer's Disease - Pipeline by Sanofi,
      • Selvita S.A.
        • Table Alzheimer's Disease - Pipeline by Selvita S.A.,
      • SeneXta Therapeutics SA
        • Table Alzheimer's Disease - Pipeline by SeneXta Therapeutics SA,
      • Serometrix, LLC
        • Table Alzheimer's Disease - Pipeline by Serometrix, LLC,
      • SignPath Pharma Inc
        • Table Alzheimer's Disease - Pipeline by SignPath Pharma Inc,
      • Signum Biosciences, Inc.
        • Table Alzheimer's Disease - Pipeline by Signum Biosciences, Inc.,
      • Simcere Pharmaceutical Group
        • Table Alzheimer's Disease - Pipeline by Simcere Pharmaceutical Group,
      • SK Biopharmaceuticals Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by SK Biopharmaceuticals Co., Ltd.,
      • SOM Innovation Biotech SL
        • Table Alzheimer's Disease - Pipeline by SOM Innovation Biotech SL,
      • Spectrum Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by Spectrum Pharmaceuticals, Inc.,
      • Stemedica Cell Technologies, Inc.
        • Table Alzheimer's Disease - Pipeline by Stemedica Cell Technologies, Inc.,
      • Sumitomo Dainippon Pharma Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by Sumitomo Dainippon Pharma Co., Ltd.,
      • Summit Therapeutics Plc
        • Table Alzheimer's Disease - Pipeline by Summit Therapeutics Plc,
      • Suven Life Sciences Ltd.
        • Table Alzheimer's Disease - Pipeline by Suven Life Sciences Ltd.,
      • T3D Therapeutics, Inc.
        • Table Alzheimer's Disease - Pipeline by T3D Therapeutics, Inc.,
      • Takeda Pharmaceutical Company Limited
        • Table Alzheimer's Disease - Pipeline by Takeda Pharmaceutical Company Limited,
      • TauRx Therapeutics Ltd.
        • Table Alzheimer's Disease - Pipeline by TauRx Therapeutics Ltd.,
      • TechnologieAllianz e. V.
        • Table Alzheimer's Disease - Pipeline by TechnologieAllianz e. V.,
      • TechnoPhage SA
        • Table Alzheimer's Disease - Pipeline by TechnoPhage SA,
      • Teijin Pharma Limited
        • Table Alzheimer's Disease - Pipeline by Teijin Pharma Limited,
      • Teikoku Pharma USA, Inc.
        • Table Alzheimer's Disease - Pipeline by Teikoku Pharma USA, Inc.,
      • Tetra Discovery Partners LLC
        • Table Alzheimer's Disease - Pipeline by Tetra Discovery Partners LLC,
      • Thera Neuropharma Inc
        • Table Alzheimer's Disease - Pipeline by Thera Neuropharma Inc,
      • Therapix Biosciences Ltd
        • Table Alzheimer's Disease - Pipeline by Therapix Biosciences Ltd,
      • Tiziana Life Sciences Plc
        • Table Alzheimer's Disease - Pipeline by Tiziana Life Sciences Plc,
      • Toyama Chemical Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by Toyama Chemical Co., Ltd.,
      • Transition Therapeutics Inc.
        • Table Alzheimer's Disease - Pipeline by Transition Therapeutics Inc.,
      • Treventis Corporation
        • Table Alzheimer's Disease - Pipeline by Treventis Corporation,
      • TyrNovo Ltd.
        • Table Alzheimer's Disease - Pipeline by TyrNovo Ltd.,
      • UCB S.A.
        • Table Alzheimer's Disease - Pipeline by UCB S.A.,
      • Varinel, Inc.
        • Table Alzheimer's Disease - Pipeline by Varinel, Inc.,
      • Vaxine Pty Ltd
        • Table Alzheimer's Disease - Pipeline by Vaxine Pty Ltd,
      • Virobay Inc.
        • Table Alzheimer's Disease - Pipeline by Virobay Inc.,
      • Vitae Pharmaceuticals, Inc.
        • Table Alzheimer's Disease - Pipeline by Vitae Pharmaceuticals, Inc.,
      • Voyager Therapeutics, Inc.
        • Table Alzheimer's Disease - Pipeline by Voyager Therapeutics, Inc.,
      • vTv Therapeutics Inc
        • Table Alzheimer's Disease - Pipeline by vTv Therapeutics Inc,
      • Vybion, Inc.
        • Table Alzheimer's Disease - Pipeline by Vybion, Inc.,
      • Wellstat Therapeutics Corporation
        • Table Alzheimer's Disease - Pipeline by Wellstat Therapeutics Corporation,
      • Zhejiang Hisun Pharmaceutical Co., Ltd.
        • Table Alzheimer's Disease - Pipeline by Zhejiang Hisun Pharmaceutical Co., Ltd.,
    • Amyotrophic Lateral Sclerosis
      • 2-BBB Medicines BV
        • Table Amyotrophic Lateral Sclerosis - Pipeline by 2-BBB Medicines BV,
      • AB Science SA
        • Table Amyotrophic Lateral Sclerosis - Pipeline by AB Science SA,
      • Aestus Therapeutics Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Aestus Therapeutics Inc,
      • Anavex Life Sciences Corp
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Anavex Life Sciences Corp,
      • Angion Biomedica Corp
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Angion Biomedica Corp,
      • Apodemus AB
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Apodemus AB,
      • Apogenix GmbH
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Apogenix GmbH,
      • Apotex Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Apotex Inc,
      • ArmaGen Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by ArmaGen Inc,
      • BioCrea GmbH
        • Table Amyotrophic Lateral Sclerosis - Pipeline by BioCrea GmbH,
      • Biogen Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Biogen Inc,
      • Biohaven Pharmaceutical Holding Company Limited
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Biohaven Pharmaceutical Holding Company Limited,
      • BioHealthonomics Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by BioHealthonomics Inc,
      • BrainStorm Cell Therapeutics Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by BrainStorm Cell Therapeutics Inc,
      • Calico LLC
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Calico LLC,
      • Catabasis Pharmaceuticals Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Catabasis Pharmaceuticals Inc,
      • Cellceutix Corp
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Cellceutix Corp,
      • Chronos Therapeutics Ltd
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Chronos Therapeutics Ltd,
      • ContraVir Pharmaceuticals Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by ContraVir Pharmaceuticals Inc,
      • Corcept Therapeutics Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Corcept Therapeutics Inc,
      • Curatis Pharma GmbH
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Curatis Pharma GmbH,
      • Cytokinetics Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Cytokinetics Inc,
      • Daval International Ltd
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Daval International Ltd,
      • Edison Pharmaceuticals Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Edison Pharmaceuticals Inc,
      • Eisai Co Ltd
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Eisai Co Ltd,
      • Ensemble Therapeutics Corp
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Ensemble Therapeutics Corp,
      • Evotec AG
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Evotec AG,
      • F. Hoffmann-La Roche Ltd
        • Table Amyotrophic Lateral Sclerosis - Pipeline by F. Hoffmann-La Roche Ltd,
      • Flex Pharma, Inc.
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Flex Pharma, Inc.,
      • FPRT Bio Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by FPRT Bio Inc,
      • Gemac
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Gemac,
      • Genentech Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Genentech Inc,
      • Genervon Biopharmaceuticals LLC
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Genervon Biopharmaceuticals LLC,
      • GeNeuro SA
        • Table Amyotrophic Lateral Sclerosis - Pipeline by GeNeuro SA,
      • GenKyoTex SA
        • Table Amyotrophic Lateral Sclerosis - Pipeline by GenKyoTex SA,
      • Glialogix Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Glialogix Inc,
      • Grifols SA
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Grifols SA,
      • Herantis Pharma Plc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Herantis Pharma Plc,
      • ImStar Therapeutics Inc.
        • Table Amyotrophic Lateral Sclerosis - Pipeline by ImStar Therapeutics Inc.,
      • InFlectis BioScience
        • Table Amyotrophic Lateral Sclerosis - Pipeline by InFlectis BioScience,
      • Ionis Pharmaceuticals Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Ionis Pharmaceuticals Inc,
      • Italfarmaco SpA
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Italfarmaco SpA,
      • Jeil Pharmaceutical Co Ltd
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Jeil Pharmaceutical Co Ltd,
      • Kadimastem Ltd
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Kadimastem Ltd,
      • Karyopharm Therapeutics Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Karyopharm Therapeutics Inc,
      • KineMed Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by KineMed Inc,
      • Kringle Pharma Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Kringle Pharma Inc,
      • Kyorin Pharmaceutical Co Ltd
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Kyorin Pharmaceutical Co Ltd,
      • Kyowa Hakko Kirin Co Ltd
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Kyowa Hakko Kirin Co Ltd,
      • Lascco SA
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Lascco SA,
      • Lead Discovery Center GmbH
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Lead Discovery Center GmbH,
      • M's Science Corp
        • Table Amyotrophic Lateral Sclerosis - Pipeline by M's Science Corp,
      • Maas Biolab
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Maas Biolab,
      • Mallinckrodt Plc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Mallinckrodt Plc,
      • MedDay SA
        • Table Amyotrophic Lateral Sclerosis - Pipeline by MedDay SA,
      • MeiraGTx Limited
        • Table Amyotrophic Lateral Sclerosis - Pipeline by MeiraGTx Limited,
      • miCure Therapeutics Ltd.
        • Table Amyotrophic Lateral Sclerosis - Pipeline by miCure Therapeutics Ltd.,
      • miRagen Therapeutics Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by miRagen Therapeutics Inc,
      • MitoDys Therapeutics Limited
        • Table Amyotrophic Lateral Sclerosis - Pipeline by MitoDys Therapeutics Limited,
      • Mitsubishi Tanabe Pharma Corp
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Mitsubishi Tanabe Pharma Corp,
      • Neuralstem Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Neuralstem Inc,
      • Neuraltus Pharmaceuticals Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Neuraltus Pharmaceuticals Inc,
      • Neurimmune Holding AG
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Neurimmune Holding AG,
      • Neurotec Pharma SL
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Neurotec Pharma SL,
      • Neurotune AG
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Neurotune AG,
      • Orion Oyj
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Orion Oyj,
      • Orphazyme ApS
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Orphazyme ApS,
      • Pharnext SA
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Pharnext SA,
      • Plex Pharmaceuticals Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Plex Pharmaceuticals Inc,
      • Prevacus Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Prevacus Inc,
      • Primary Peptides, Inc.
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Primary Peptides, Inc.,
      • ProMIS Neurosciences Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by ProMIS Neurosciences Inc,
      • Q Therapeutics Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Q Therapeutics Inc,
      • ReceptoPharm Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by ReceptoPharm Inc,
      • Regenesance BV
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Regenesance BV,
      • reMYND NV
        • Table Amyotrophic Lateral Sclerosis - Pipeline by reMYND NV,
      • Saneron CCEL Therapeutics Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Saneron CCEL Therapeutics Inc,
      • SciFluor Life Sciences LLC
        • Table Amyotrophic Lateral Sclerosis - Pipeline by SciFluor Life Sciences LLC,
      • SK Biopharmaceuticals Co Ltd
        • Table Amyotrophic Lateral Sclerosis - Pipeline by SK Biopharmaceuticals Co Ltd,
      • Spherium Biomed SL
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Spherium Biomed SL,
      • Symic Biomedical Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Symic Biomedical Inc,
      • Teva Pharmaceutical Industries Ltd
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Teva Pharmaceutical Industries Ltd,
      • Thera Neuropharma Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Thera Neuropharma Inc,
      • Treeway BV
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Treeway BV,
      • Valeant Pharmaceuticals International Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Valeant Pharmaceuticals International Inc,
      • ViroMed Co Ltd
        • Table Amyotrophic Lateral Sclerosis - Pipeline by ViroMed Co Ltd,
      • VivaCell Biotechnology Espana SL
        • Table Amyotrophic Lateral Sclerosis - Pipeline by VivaCell Biotechnology Espana SL,
      • Voyager Therapeutics Inc
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Voyager Therapeutics Inc,
      • WAVE Life Sciences Ltd
        • Table Amyotrophic Lateral Sclerosis - Pipeline by WAVE Life Sciences Ltd,
      • Yooyoung Pharmaceutical Co Ltd
        • Table Amyotrophic Lateral Sclerosis - Pipeline by Yooyoung Pharmaceutical Co Ltd,
    • Huntington Disease
      • Addex Therapeutics Ltd
        • Table Huntington Disease - Pipeline by Addex Therapeutics Ltd,
      • AFFiRiS AG
        • Table Huntington Disease - Pipeline by AFFiRiS AG,
      • Angita BV
        • Table Huntington Disease - Pipeline by Angita BV,
      • Annexon Inc
        • Table Huntington Disease - Pipeline by Annexon Inc,
      • Astellas Pharma Inc
        • Table Huntington Disease - Pipeline by Astellas Pharma Inc,
      • Azevan Pharmaceuticals Inc
        • Table Huntington Disease - Pipeline by Azevan Pharmaceuticals Inc,
      • BioCrea GmbH
        • Table Huntington Disease - Pipeline by BioCrea GmbH,
      • BrainStorm Cell Therapeutics Inc
        • Table Huntington Disease - Pipeline by BrainStorm Cell Therapeutics Inc,
      • Celon Pharma Sp z oo
        • Table Huntington Disease - Pipeline by Celon Pharma Sp z oo,
      • Chong Kun Dang Pharmaceutical Corp
        • Table Huntington Disease - Pipeline by Chong Kun Dang Pharmaceutical Corp,
      • Diffusion Pharmaceuticals Inc
        • Table Huntington Disease - Pipeline by Diffusion Pharmaceuticals Inc,
      • EncephRx Inc
        • Table Huntington Disease - Pipeline by EncephRx Inc,
      • Evotec AG
        • Table Huntington Disease - Pipeline by Evotec AG,
      • Galenea Corp
        • Table Huntington Disease - Pipeline by Galenea Corp,
      • Genervon Biopharmaceuticals LLC
        • Table Huntington Disease - Pipeline by Genervon Biopharmaceuticals LLC,
      • Horizon Pharma Plc
        • Table Huntington Disease - Pipeline by Horizon Pharma Plc,
      • Immungenetics AG
        • Table Huntington Disease - Pipeline by Immungenetics AG,
      • Ionis Pharmaceuticals Inc
        • Table Huntington Disease - Pipeline by Ionis Pharmaceuticals Inc,
      • Ipsen SA
        • Table Huntington Disease - Pipeline by Ipsen SA,
      • Kadmon Corp LLC
        • Table Huntington Disease - Pipeline by Kadmon Corp LLC,
      • KineMed Inc
        • Table Huntington Disease - Pipeline by KineMed Inc,
      • Krenitsky Pharmaceuticals Inc
        • Table Huntington Disease - Pipeline by Krenitsky Pharmaceuticals Inc,
      • Living Cell Technologies Ltd
        • Table Huntington Disease - Pipeline by Living Cell Technologies Ltd,
      • Medesis Pharma SA
        • Table Huntington Disease - Pipeline by Medesis Pharma SA,
      • Mitochon Pharmaceuticals Inc
        • Table Huntington Disease - Pipeline by Mitochon Pharmaceuticals Inc,
      • Neuralstem Inc
        • Table Huntington Disease - Pipeline by Neuralstem Inc,
      • Neurimmune Holding AG
        • Table Huntington Disease - Pipeline by Neurimmune Holding AG,
      • NeuroNascent Inc
        • Table Huntington Disease - Pipeline by NeuroNascent Inc,
      • New World Laboratories Inc
        • Table Huntington Disease - Pipeline by New World Laboratories Inc,
      • nLife Therapeutics SL
        • Table Huntington Disease - Pipeline by nLife Therapeutics SL,
      • NsGene A/S
        • Table Huntington Disease - Pipeline by NsGene A/S,
      • Omeros Corp
        • Table Huntington Disease - Pipeline by Omeros Corp,
      • Oryzon Genomics SA
        • Table Huntington Disease - Pipeline by Oryzon Genomics SA,
      • Pfizer Inc
        • Table Huntington Disease - Pipeline by Pfizer Inc,
      • PharmatrophiX Inc
        • Table Huntington Disease - Pipeline by PharmatrophiX Inc,
      • ProQR Therapeutics NV
        • Table Huntington Disease - Pipeline by ProQR Therapeutics NV,
      • QR Pharma Inc
        • Table Huntington Disease - Pipeline by QR Pharma Inc,
      • reMYND NV
        • Table Huntington Disease - Pipeline by reMYND NV,
      • Retrotope Inc
        • Table Huntington Disease - Pipeline by Retrotope Inc,
      • Rhenovia Pharma Ltd
        • Table Huntington Disease - Pipeline by Rhenovia Pharma Ltd,
      • Shire Plc
        • Table Huntington Disease - Pipeline by Shire Plc,
      • SOM Biotech SL
        • Table Huntington Disease - Pipeline by SOM Biotech SL,
      • Spark Therapeutics Inc
        • Table Huntington Disease - Pipeline by Spark Therapeutics Inc,
      • Teva Pharmaceutical Industries Ltd
        • Table Huntington Disease - Pipeline by Teva Pharmaceutical Industries Ltd,
      • TyrNovo Ltd
        • Table Huntington Disease - Pipeline by TyrNovo Ltd,
      • Ultragenyx Pharmaceutical Inc
        • Table Huntington Disease - Pipeline by Ultragenyx Pharmaceutical Inc,
      • UniQure NV
        • Table Huntington Disease - Pipeline by UniQure NV,
      • Vaccinex Inc
        • Table Huntington Disease - Pipeline by Vaccinex Inc,
      • Vertex Pharmaceuticals Inc
        • Table Huntington Disease - Pipeline by Vertex Pharmaceuticals Inc,
      • VistaGen Therapeutics Inc
        • Table Huntington Disease - Pipeline by VistaGen Therapeutics Inc,
      • Vitality Biopharma Inc
        • Table Huntington Disease - Pipeline by Vitality Biopharma Inc,
      • VivaCell Biotechnology Espana SL
        • Table Huntington Disease - Pipeline by VivaCell Biotechnology Espana SL,
      • Voyager Therapeutics Inc
        • Table Huntington Disease - Pipeline by Voyager Therapeutics Inc,
      • Vybion Inc
        • Table Huntington Disease - Pipeline by Vybion Inc,
      • WAVE Life Sciences Ltd
        • Table Huntington Disease - Pipeline by WAVE Life Sciences Ltd,
      • Wellstat Therapeutics Corp
        • Table Huntington Disease - Pipeline by Wellstat Therapeutics Corp,
    • Multiple Sclerosis
      • 2-BBB Medicines BV
        • Table Multiple Sclerosis - Pipeline by 2-BBB Medicines BV,
      • 4D Pharma Plc
        • Table Multiple Sclerosis - Pipeline by 4D Pharma Plc,
      • AB Science SA
        • Table Multiple Sclerosis - Pipeline by AB Science SA,
      • AbbVie Inc
        • Table Multiple Sclerosis - Pipeline by AbbVie Inc,
      • Abion Inc
        • Table Multiple Sclerosis - Pipeline by Abion Inc,
      • Ablynx NV
        • Table Multiple Sclerosis - Pipeline by Ablynx NV,
      • Abzena Plc
        • Table Multiple Sclerosis - Pipeline by Abzena Plc,
      • Acorda Therapeutics Inc
        • Table Multiple Sclerosis - Pipeline by Acorda Therapeutics Inc,
      • Actelion Ltd
        • Table Multiple Sclerosis - Pipeline by Actelion Ltd,
      • Adamas Pharmaceuticals Inc
        • Table Multiple Sclerosis - Pipeline by Adamas Pharmaceuticals Inc,
      • Addex Therapeutics Ltd
        • Table Multiple Sclerosis - Pipeline by Addex Therapeutics Ltd,
      • Adhaere Pharmaceuticals Inc
        • Table Multiple Sclerosis - Pipeline by Adhaere Pharmaceuticals Inc,
      • Aegis Therapeutics LLC
        • Table Multiple Sclerosis - Pipeline by Aegis Therapeutics LLC,
      • Affectis Pharmaceuticals AG
        • Table Multiple Sclerosis - Pipeline by Affectis Pharmaceuticals AG,
      • AiCuris GmbH & Co KG
        • Table Multiple Sclerosis - Pipeline by AiCuris GmbH & Co KG,
      • Alkermes Plc
        • Table Multiple Sclerosis - Pipeline by Alkermes Plc,
      • Alpha Cancer Technologies Inc
        • Table Multiple Sclerosis - Pipeline by Alpha Cancer Technologies Inc,
      • Amarna Therapeutics BV
        • Table Multiple Sclerosis - Pipeline by Amarna Therapeutics BV,
      • Anavex Life Sciences Corp
        • Table Multiple Sclerosis - Pipeline by Anavex Life Sciences Corp,
      • Antisense Therapeutics Ltd
        • Table Multiple Sclerosis - Pipeline by Antisense Therapeutics Ltd,
      • Aphios Corp
        • Table Multiple Sclerosis - Pipeline by Aphios Corp,
      • Apitope International NV
        • Table Multiple Sclerosis - Pipeline by Apitope International NV,
      • ARA Healthcare Pvt Ltd
        • Table Multiple Sclerosis - Pipeline by ARA Healthcare Pvt Ltd,
      • Arena Pharmaceuticals Inc
        • Table Multiple Sclerosis - Pipeline by Arena Pharmaceuticals Inc,
      • arGEN-X BV
        • Table Multiple Sclerosis - Pipeline by arGEN-X BV,
      • Argos Therapeutics Inc
        • Table Multiple Sclerosis - Pipeline by Argos Therapeutics Inc,
      • Arrien Pharmaceuticals LLC
        • Table Multiple Sclerosis - Pipeline by Arrien Pharmaceuticals LLC,
      • Artielle ImmunoTherapeutics Inc
        • Table Multiple Sclerosis - Pipeline by Artielle ImmunoTherapeutics Inc,
      • Astellas Pharma Inc
        • Table Multiple Sclerosis - Pipeline by Astellas Pharma Inc,
      • Asterias Biotherapeutics Inc
        • Table Multiple Sclerosis - Pipeline by Asterias Biotherapeutics Inc,
      • Atara Biotherapeutics Inc
        • Table Multiple Sclerosis - Pipeline by Atara Biotherapeutics Inc,
      • Athersys Inc
        • Table Multiple Sclerosis - Pipeline by Athersys Inc,
      • Atlantic Bio Sci LLC
        • Table Multiple Sclerosis - Pipeline by Atlantic Bio Sci LLC,
      • Axxam SpA
        • Table Multiple Sclerosis - Pipeline by Axxam SpA,
      • Baliopharm AG
        • Table Multiple Sclerosis - Pipeline by Baliopharm AG,
      • Bio-Cancer Treatment International Ltd
        • Table Multiple Sclerosis - Pipeline by Bio-Cancer Treatment International Ltd,
      • BioAegis Therapeutics Inc
        • Table Multiple Sclerosis - Pipeline by BioAegis Therapeutics Inc,
      • BioApex sro
        • Table Multiple Sclerosis - Pipeline by BioApex sro,
      • Biocad
        • Table Multiple Sclerosis - Pipeline by Biocad,
      • Biocon Ltd
        • Table Multiple Sclerosis - Pipeline by Biocon Ltd,
      • Biogen Inc
        • Table Multiple Sclerosis - Pipeline by Biogen Inc,
      • Biogenomics Ltd
        • Table Multiple Sclerosis - Pipeline by Biogenomics Ltd,
      • BioHealthonomics Inc
        • Table Multiple Sclerosis - Pipeline by BioHealthonomics Inc,
      • Biokine Therapeutics Ltd
        • Table Multiple Sclerosis - Pipeline by Biokine Therapeutics Ltd,
      • Biomar Microbial Technologies
        • Table Multiple Sclerosis - Pipeline by Biomar Microbial Technologies,
      • Bioncotech Therapeutics SL
        • Table Multiple Sclerosis - Pipeline by Bioncotech Therapeutics SL,
      • Bionovis SA
        • Table Multiple Sclerosis - Pipeline by Bionovis SA,
      • Bionure Farma SL
        • Table Multiple Sclerosis - Pipeline by Bionure Farma SL,
      • Biovista Inc
        • Table Multiple Sclerosis - Pipeline by Biovista Inc,
      • Bolder Biotechnology Inc
        • Table Multiple Sclerosis - Pipeline by Bolder Biotechnology Inc,
      • BrainStorm Cell Therapeutics Inc
        • Table Multiple Sclerosis - Pipeline by BrainStorm Cell Therapeutics Inc,
      • Bristol-Myers Squibb Company
        • Table Multiple Sclerosis - Pipeline by Bristol-Myers Squibb Company,
      • C4X Discovery Holdings PLC
        • Table Multiple Sclerosis - Pipeline by C4X Discovery Holdings PLC,
      • CASI Pharmaceuticals Inc
        • Table Multiple Sclerosis - Pipeline by CASI Pharmaceuticals Inc,
      • Catalyst Pharmaceuticals Inc
        • Table Multiple Sclerosis - Pipeline by Catalyst Pharmaceuticals Inc,
      • Celgene Corp
        • Table Multiple Sclerosis - Pipeline by Celgene Corp,
      • Cell Cure Neurosciences Ltd
        • Table Multiple Sclerosis - Pipeline by Cell Cure Neurosciences Ltd,
      • Cell2B Advanced Therapeutics SA
        • Table Multiple Sclerosis - Pipeline by Cell2B Advanced Therapeutics SA,
      • Cellceutix Corp
        • Table Multiple Sclerosis - Pipeline by Cellceutix Corp,
      • Cognosci Inc
        • Table Multiple Sclerosis - Pipeline by Cognosci Inc,
      • Coherus BioSciences Inc
        • Table Multiple Sclerosis - Pipeline by Coherus BioSciences Inc,
      • Commence Bio Inc
        • Table Multiple Sclerosis - Pipeline by Commence Bio Inc,
      • Compugen Ltd
        • Table Multiple Sclerosis - Pipeline by Compugen Ltd,
      • Connexios Life Sciences Pvt Ltd
        • Table Multiple Sclerosis - Pipeline by Connexios Life Sciences Pvt Ltd,
      • Critical Outcome Technologies Inc
        • Table Multiple Sclerosis - Pipeline by Critical Outcome Technologies Inc,
      • CuraVac Inc
        • Table Multiple Sclerosis - Pipeline by CuraVac Inc,
      • Cyxone AB
        • Table Multiple Sclerosis - Pipeline by Cyxone AB,
      • Daiichi Sankyo Company Ltd
        • Table Multiple Sclerosis - Pipeline by Daiichi Sankyo Company Ltd,
      • Dimerix Bioscience Pty Ltd
        • Table Multiple Sclerosis - Pipeline by Dimerix Bioscience Pty Ltd,
      • Dong-A Socio Holdings Co Ltd
        • Table Multiple Sclerosis - Pipeline by Dong-A Socio Holdings Co Ltd,
      • Eisai Co Ltd
        • Table Multiple Sclerosis - Pipeline by Eisai Co Ltd,
      • Eli Lilly and Company
        • Table Multiple Sclerosis - Pipeline by Eli Lilly and Company,
      • Endece LLC
        • Table Multiple Sclerosis - Pipeline by Endece LLC,
      • Evgen Pharma Plc
        • Table Multiple Sclerosis - Pipeline by Evgen Pharma Plc,
      • Evotec AG
        • Table Multiple Sclerosis - Pipeline by Evotec AG,
      • F. Hoffmann-La Roche Ltd
        • Table Multiple Sclerosis - Pipeline by F. Hoffmann-La Roche Ltd,
      • Flex Pharma Inc
        • Table Multiple Sclerosis - Pipeline by Flex Pharma Inc,
      • Forward Pharma A/S
        • Table Multiple Sclerosis - Pipeline by Forward Pharma A/S,
      • FPRT Bio Inc
        • Table Multiple Sclerosis - Pipeline by FPRT Bio Inc,
      • Gemac SA
        • Table Multiple Sclerosis - Pipeline by Gemac SA,
      • Genervon Biopharmaceuticals LLC
        • Table Multiple Sclerosis - Pipeline by Genervon Biopharmaceuticals LLC,
      • GeNeuro SA
        • Table Multiple Sclerosis - Pipeline by GeNeuro SA,
      • Genzyme Corp
        • Table Multiple Sclerosis - Pipeline by Genzyme Corp,
      • GlaxoSmithKline Plc
        • Table Multiple Sclerosis - Pipeline by GlaxoSmithKline Plc,
      • Glenmark Pharmaceuticals Ltd
        • Table Multiple Sclerosis - Pipeline by Glenmark Pharmaceuticals Ltd,
      • Glialogix Inc
        • Table Multiple Sclerosis - Pipeline by Glialogix Inc,
      • Hansa Medical AB
        • Table Multiple Sclerosis - Pipeline by Hansa Medical AB,
      • Harbor Therapeutics Inc
        • Table Multiple Sclerosis - Pipeline by Harbor Therapeutics Inc,
      • HitGen LTD
        • Table Multiple Sclerosis - Pipeline by HitGen LTD,
      • Humabs BioMed SA
        • Table Multiple Sclerosis - Pipeline by Humabs BioMed SA,
      • Hutchison MediPharma Ltd
        • Table Multiple Sclerosis - Pipeline by Hutchison MediPharma Ltd,
      • Iltoo Pharma
        • Table Multiple Sclerosis - Pipeline by Iltoo Pharma,
      • Immune Response BioPharma Inc
        • Table Multiple Sclerosis - Pipeline by Immune Response BioPharma Inc,
      • Immune Therapeutics Inc
        • Table Multiple Sclerosis - Pipeline by Immune Therapeutics Inc,
      • ImmuNext Inc
        • Table Multiple Sclerosis - Pipeline by ImmuNext Inc,
      • Immungenetics AG
        • Table Multiple Sclerosis - Pipeline by Immungenetics AG,
      • Inception Sciences Inc
        • Table Multiple Sclerosis - Pipeline by Inception Sciences Inc,
      • Innate Immunotherapeutics Ltd
        • Table Multiple Sclerosis - Pipeline by Innate Immunotherapeutics Ltd,
      • Inovio Pharmaceuticals Inc
        • Table Multiple Sclerosis - Pipeline by Inovio Pharmaceuticals Inc,
      • Io Therapeutics Inc
        • Table Multiple Sclerosis - Pipeline by Io Therapeutics Inc,
      • Jyant Technologies Inc
        • Table Multiple Sclerosis - Pipeline by Jyant Technologies Inc,
      • Kadimastem Ltd
        • Table Multiple Sclerosis - Pipeline by Kadimastem Ltd,
      • Kadmon Corp LLC
        • Table Multiple Sclerosis - Pipeline by Kadmon Corp LLC,
      • KAHR medical Ltd
        • Table Multiple Sclerosis - Pipeline by KAHR medical Ltd,
      • KaloBios Pharmaceuticals Inc
        • Table Multiple Sclerosis - Pipeline by KaloBios Pharmaceuticals Inc,
      • Kancera AB
        • Table Multiple Sclerosis - Pipeline by Kancera AB,
      • Kareus Therapeutics SA
        • Table Multiple Sclerosis - Pipeline by Kareus Therapeutics SA,
      • Karo Pharma AB
        • Table Multiple Sclerosis - Pipeline by Karo Pharma AB,
      • Karyopharm Therapeutics Inc
        • Table Multiple Sclerosis - Pipeline by Karyopharm Therapeutics Inc,
      • Kissei Pharmaceutical Co Ltd
        • Table Multiple Sclerosis - Pipeline by Kissei Pharmaceutical Co Ltd,
      • KPI Therapeutics Inc
        • Table Multiple Sclerosis - Pipeline by KPI Therapeutics Inc,
      • Kyorin Pharmaceutical Co Ltd
        • Table Multiple Sclerosis - Pipeline by Kyorin Pharmaceutical Co Ltd,
      • Lead Discovery Center GmbH
        • Table Multiple Sclerosis - Pipeline by Lead Discovery Center GmbH,
      • LFB SA
        • Table Multiple Sclerosis - Pipeline by LFB SA,
      • Lipocure Ltd
        • Table Multiple Sclerosis - Pipeline by Lipocure Ltd,
      • MacroGenics Inc
        • Table Multiple Sclerosis - Pipeline by MacroGenics Inc,
      • MAKScientific LLC
        • Table Multiple Sclerosis - Pipeline by MAKScientific LLC,
      • Mapi Pharma Ltd
        • Table Multiple Sclerosis - Pipeline by Mapi Pharma Ltd,
      • Marathon Pharmaceuticals LLC
        • Table Multiple Sclerosis - Pipeline by Marathon Pharmaceuticals LLC,
      • MedAnnex Ltd
        • Table Multiple Sclerosis - Pipeline by MedAnnex Ltd,
      • MedDay SA
        • Table Multiple Sclerosis - Pipeline by MedDay SA,
      • Medestea Research & Production SpA
        • Table Multiple Sclerosis - Pipeline by Medestea Research & Production SpA,
      • MedImmune LLC
        • Table Multiple Sclerosis - Pipeline by MedImmune LLC,
      • Merck KGaA
        • Table Multiple Sclerosis - Pipeline by Merck KGaA,
      • Meta-IQ ApS
        • Table Multiple Sclerosis - Pipeline by Meta-IQ ApS,
      • Mitochon Pharmaceuticals Inc
        • Table Multiple Sclerosis - Pipeline by Mitochon Pharmaceuticals Inc,
      • Mitsubishi Tanabe Pharma Corp
        • Table Multiple Sclerosis - Pipeline by Mitsubishi Tanabe Pharma Corp,
      • MorphoSys AG
        • Table Multiple Sclerosis - Pipeline by MorphoSys AG,
      • Mount Tam Biotechnologies Inc
        • Table Multiple Sclerosis - Pipeline by Mount Tam Biotechnologies Inc,
      • Neuralstem Inc
        • Table Multiple Sclerosis - Pipeline by Neuralstem Inc,
      • Neuren Pharmaceuticals Ltd
        • Table Multiple Sclerosis - Pipeline by Neuren Pharmaceuticals Ltd,
      • Neuronax SAS
        • Table Multiple Sclerosis - Pipeline by Neuronax SAS,
      • Neurotec Pharma SL
        • Table Multiple Sclerosis - Pipeline by Neurotec Pharma SL,
      • New World Laboratories Inc
        • Table Multiple Sclerosis - Pipeline by New World Laboratories Inc,
      • Novartis AG
        • Table Multiple Sclerosis - Pipeline by Novartis AG,
      • NovImmune SA
        • Table Multiple Sclerosis - Pipeline by NovImmune SA,
      • Nuevolution AB
        • Table Multiple Sclerosis - Pipeline by Nuevolution AB,
      • Ogeda SA
        • Table Multiple Sclerosis - Pipeline by Ogeda SA,
      • Omeros Corp
        • Table Multiple Sclerosis - Pipeline by Omeros Corp,
      • OncoImmune Inc
        • Table Multiple Sclerosis - Pipeline by OncoImmune Inc,
      • Opexa Therapeutics Inc
        • Table Multiple Sclerosis - Pipeline by Opexa Therapeutics Inc,
      • Oryzon Genomics SA
        • Table Multiple Sclerosis - Pipeline by Oryzon Genomics SA,
      • OSE Immunotherapeutics
        • Table Multiple Sclerosis - Pipeline by OSE Immunotherapeutics,
      • Parvus Therapeutics Inc
        • Table Multiple Sclerosis - Pipeline by Parvus Therapeutics Inc,
      • Peptinov SAS
        • Table Multiple Sclerosis - Pipeline by Peptinov SAS,
      • Pfenex Inc
        • Table Multiple Sclerosis - Pipeline by Pfenex Inc,
      • Pfizer Inc
        • Table Multiple Sclerosis - Pipeline by Pfizer Inc,
      • PharmaEssentia Corp
        • Table Multiple Sclerosis - Pipeline by PharmaEssentia Corp,
      • PharmatrophiX Inc
        • Table Multiple Sclerosis - Pipeline by PharmatrophiX Inc,
      • Pharmaxis Ltd
        • Table Multiple Sclerosis - Pipeline by Pharmaxis Ltd,
      • Pieris Pharmaceuticals Inc
        • Table Multiple Sclerosis - Pipeline by Pieris Pharmaceuticals Inc,
      • Polleo Pharma Ltd
        • Table Multiple Sclerosis - Pipeline by Polleo Pharma Ltd,
      • ProNoxis AB
        • Table Multiple Sclerosis - Pipeline by ProNoxis AB,
      • Prothena Corp Plc
        • Table Multiple Sclerosis - Pipeline by Prothena Corp Plc,
      • Q Therapeutics Inc
        • Table Multiple Sclerosis - Pipeline by Q Therapeutics Inc,
      • ReceptoPharm Inc
        • Table Multiple Sclerosis - Pipeline by ReceptoPharm Inc,
      • RedHill Biopharma Ltd
        • Table Multiple Sclerosis - Pipeline by RedHill Biopharma Ltd,
      • RegeneRx Biopharmaceuticals Inc
        • Table Multiple Sclerosis - Pipeline by RegeneRx Biopharmaceuticals Inc,
      • Regenesance BV
        • Table Multiple Sclerosis - Pipeline by Regenesance BV,
      • Renovo Neural Inc
        • Table Multiple Sclerosis - Pipeline by Renovo Neural Inc,
      • Resverlogix Corp
        • Table Multiple Sclerosis - Pipeline by Resverlogix Corp,
      • ReveraGen BioPharma Inc
        • Table Multiple Sclerosis - Pipeline by ReveraGen BioPharma Inc,
      • Rigel Pharmaceuticals Inc
        • Table Multiple Sclerosis - Pipeline by Rigel Pharmaceuticals Inc,
      • Rodos BioTarget GmbH
        • Table Multiple Sclerosis - Pipeline by Rodos BioTarget GmbH,
      • SanBio Inc
        • Table Multiple Sclerosis - Pipeline by SanBio Inc,
      • Santhera Pharmaceuticals Holding AG
        • Table Multiple Sclerosis - Pipeline by Santhera Pharmaceuticals Holding AG,
      • Sareum Holdings Plc
        • Table Multiple Sclerosis - Pipeline by Sareum Holdings Plc,
      • Sorrento Therapeutics Inc
        • Table Multiple Sclerosis - Pipeline by Sorrento Therapeutics Inc,
      • Symic Biomedical Inc
        • Table Multiple Sclerosis - Pipeline by Symic Biomedical Inc,
      • Synthon Holdings BV
        • Table Multiple Sclerosis - Pipeline by Synthon Holdings BV,
      • Targazyme Inc
        • Table Multiple Sclerosis - Pipeline by Targazyme Inc,
      • Teikoku Pharma USA Inc
        • Table Multiple Sclerosis - Pipeline by Teikoku Pharma USA Inc,
      • Teva Pharmaceutical Industries Ltd
        • Table Multiple Sclerosis - Pipeline by Teva Pharmaceutical Industries Ltd,
      • Therapix Biosciences Ltd
        • Table Multiple Sclerosis - Pipeline by Therapix Biosciences Ltd,
      • TikoMed AB
        • Table Multiple Sclerosis - Pipeline by TikoMed AB,
      • Toleranzia AB
        • Table Multiple Sclerosis - Pipeline by Toleranzia AB,
      • Topas Therapeutics GmbH
        • Table Multiple Sclerosis - Pipeline by Topas Therapeutics GmbH,
      • TxCell SA
        • Table Multiple Sclerosis - Pipeline by TxCell SA,
      • Vaccinex Inc
        • Table Multiple Sclerosis - Pipeline by Vaccinex Inc,
      • Vakzine Projekt Management GmbH
        • Table Multiple Sclerosis - Pipeline by Vakzine Projekt Management GmbH,
      • Virogenomics BioDevelopment Inc
        • Table Multiple Sclerosis - Pipeline by Virogenomics BioDevelopment Inc,
      • Vitae Pharmaceuticals Inc
        • Table Multiple Sclerosis - Pipeline by Vitae Pharmaceuticals Inc,
      • VivaCell Biotechnology Espana SL
        • Table Multiple Sclerosis - Pipeline by VivaCell Biotechnology Espana SL,
      • Xenetic Biosciences (UK) Ltd
        • Table Multiple Sclerosis - Pipeline by Xenetic Biosciences (UK) Ltd,
      • XL-protein GmbH
        • Table Multiple Sclerosis - Pipeline by XL-protein GmbH,
      • Yungjin Pharm Co Ltd
        • Table Multiple Sclerosis - Pipeline by Yungjin Pharm Co Ltd,
      • Zenith Capital Corp
        • Table Multiple Sclerosis - Pipeline by Zenith Capital Corp,
      • Zydus Cadila Healthcare Ltd
        • Table Multiple Sclerosis - Pipeline by Zydus Cadila Healthcare Ltd,
    • Parkinson's Disease
      • 2-BBB Medicines BV
        • Table Parkinson's Disease - Pipeline by 2-BBB Medicines BV,
      • 4P Therapeutics LLC
        • Table Parkinson's Disease - Pipeline by 4P Therapeutics LLC,
      • AbbVie Inc
        • Table Parkinson's Disease - Pipeline by AbbVie Inc,
      • AC Immune SA
        • Table Parkinson's Disease - Pipeline by AC Immune SA,
      • Acelot Inc
        • Table Parkinson's Disease - Pipeline by Acelot Inc,
      • Acorda Therapeutics Inc
        • Table Parkinson's Disease - Pipeline by Acorda Therapeutics Inc,
      • Adamas Pharmaceuticals Inc
        • Table Parkinson's Disease - Pipeline by Adamas Pharmaceuticals Inc,
      • Addex Therapeutics Ltd
        • Table Parkinson's Disease - Pipeline by Addex Therapeutics Ltd,
      • Advinus Therapeutics Ltd
        • Table Parkinson's Disease - Pipeline by Advinus Therapeutics Ltd,
      • Aeolus Pharmaceuticals Inc
        • Table Parkinson's Disease - Pipeline by Aeolus Pharmaceuticals Inc,
      • AFFiRiS AG
        • Table Parkinson's Disease - Pipeline by AFFiRiS AG,
      • Amabiotics SAS
        • Table Parkinson's Disease - Pipeline by Amabiotics SAS,
      • Amarantus Bioscience Holdings Inc
        • Table Parkinson's Disease - Pipeline by Amarantus Bioscience Holdings Inc,
      • American Gene Technologies International Inc
        • Table Parkinson's Disease - Pipeline by American Gene Technologies International Inc,
      • Anavex Life Sciences Corp
        • Table Parkinson's Disease - Pipeline by Anavex Life Sciences Corp,
      • Angita BV
        • Table Parkinson's Disease - Pipeline by Angita BV,
      • Antoxis Ltd
        • Table Parkinson's Disease - Pipeline by Antoxis Ltd,
      • Aoxing Pharmaceutical Company Inc
        • Table Parkinson's Disease - Pipeline by Aoxing Pharmaceutical Company Inc,
      • APeT Holding BV
        • Table Parkinson's Disease - Pipeline by APeT Holding BV,
      • ApoPharma Inc
        • Table Parkinson's Disease - Pipeline by ApoPharma Inc,
      • Aposense Ltd
        • Table Parkinson's Disease - Pipeline by Aposense Ltd,
      • Araclon Biotech SL
        • Table Parkinson's Disease - Pipeline by Araclon Biotech SL,
      • ArmaGen Inc
        • Table Parkinson's Disease - Pipeline by ArmaGen Inc,
      • Arrien Pharmaceuticals LLC
        • Table Parkinson's Disease - Pipeline by Arrien Pharmaceuticals LLC,
      • AstraZeneca Plc
        • Table Parkinson's Disease - Pipeline by AstraZeneca Plc,
      • AudioCure Pharma GmbH
        • Table Parkinson's Disease - Pipeline by AudioCure Pharma GmbH,
      • Berg LLC
        • Table Parkinson's Disease - Pipeline by Berg LLC,
      • Bial - Portela & Ca SA
        • Table Parkinson's Disease - Pipeline by Bial - Portela & Ca SA,
      • Bio-Modeling Systems SAS
        • Table Parkinson's Disease - Pipeline by Bio-Modeling Systems SAS,
      • BioArtic AB
        • Table Parkinson's Disease - Pipeline by BioArtic AB,
      • Biogen Inc
        • Table Parkinson's Disease - Pipeline by Biogen Inc,
      • BioHealthonomics Inc
        • Table Parkinson's Disease - Pipeline by BioHealthonomics Inc,
      • Biopharm GmbH
        • Table Parkinson's Disease - Pipeline by Biopharm GmbH,
      • Biotie Therapies Corp
        • Table Parkinson's Disease - Pipeline by Biotie Therapies Corp,
      • BrainStorm Cell Therapeutics Inc
        • Table Parkinson's Disease - Pipeline by BrainStorm Cell Therapeutics Inc,
      • Calico LLC
        • Table Parkinson's Disease - Pipeline by Calico LLC,
      • Cantabio Pharmaceuticals Inc
        • Table Parkinson's Disease - Pipeline by Cantabio Pharmaceuticals Inc,
      • Cardax Inc
        • Table Parkinson's Disease - Pipeline by Cardax Inc,
      • Carna Biosciences Inc
        • Table Parkinson's Disease - Pipeline by Carna Biosciences Inc,
      • Cell Cure Neurosciences Ltd
        • Table Parkinson's Disease - Pipeline by Cell Cure Neurosciences Ltd,
      • Cellceutix Corp
        • Table Parkinson's Disease - Pipeline by Cellceutix Corp,
      • CHA Bio & Diostech Co Ltd
        • Table Parkinson's Disease - Pipeline by CHA Bio & Diostech Co Ltd,
      • Chipscreen Biosciences Ltd
        • Table Parkinson's Disease - Pipeline by Chipscreen Biosciences Ltd,
      • Clera Inc
        • Table Parkinson's Disease - Pipeline by Clera Inc,
      • Clevexel Pharma SA
        • Table Parkinson's Disease - Pipeline by Clevexel Pharma SA,
      • Contera Pharma ApS
        • Table Parkinson's Disease - Pipeline by Contera Pharma ApS,
      • ContraVir Pharmaceuticals Inc
        • Table Parkinson's Disease - Pipeline by ContraVir Pharmaceuticals Inc,
      • Corium International Inc
        • Table Parkinson's Disease - Pipeline by Corium International Inc,
      • Curemark LLC
        • Table Parkinson's Disease - Pipeline by Curemark LLC,
      • Daewoong Pharmaceutical Co Ltd
        • Table Parkinson's Disease - Pipeline by Daewoong Pharmaceutical Co Ltd,
      • Denali Therapeutics Inc
        • Table Parkinson's Disease - Pipeline by Denali Therapeutics Inc,
      • Depomed Inc
        • Table Parkinson's Disease - Pipeline by Depomed Inc,
      • DermaXon LLC
        • Table Parkinson's Disease - Pipeline by DermaXon LLC,
      • Diffusion Pharmaceuticals Inc
        • Table Parkinson's Disease - Pipeline by Diffusion Pharmaceuticals Inc,
      • Dizlin Medical Design AB
        • Table Parkinson's Disease - Pipeline by Dizlin Medical Design AB,
      • Domain Therapeutics SA
        • Table Parkinson's Disease - Pipeline by Domain Therapeutics SA,
      • Edison Pharmaceuticals Inc
        • Table Parkinson's Disease - Pipeline by Edison Pharmaceuticals Inc,
      • Eli Lilly and Company
        • Table Parkinson's Disease - Pipeline by Eli Lilly and Company,
      • Ensemble Therapeutics Corp
        • Table Parkinson's Disease - Pipeline by Ensemble Therapeutics Corp,
      • Fabre-Kramer Pharmaceuticals Inc
        • Table Parkinson's Disease - Pipeline by Fabre-Kramer Pharmaceuticals Inc,
      • FPRT Bio Inc
        • Table Parkinson's Disease - Pipeline by FPRT Bio Inc,
      • Genecode AS
        • Table Parkinson's Disease - Pipeline by Genecode AS,
      • Generon (Shanghai) Corp Ltd
        • Table Parkinson's Disease - Pipeline by Generon (Shanghai) Corp Ltd,
      • Genervon Biopharmaceuticals LLC
        • Table Parkinson's Disease - Pipeline by Genervon Biopharmaceuticals LLC,
      • GenKyoTex SA
        • Table Parkinson's Disease - Pipeline by GenKyoTex SA,
      • Genmab A/S
        • Table Parkinson's Disease - Pipeline by Genmab A/S,
      • Genosco Inc
        • Table Parkinson's Disease - Pipeline by Genosco Inc,
      • Genzyme Corp
        • Table Parkinson's Disease - Pipeline by Genzyme Corp,
      • H. Lundbeck A/S
        • Table Parkinson's Disease - Pipeline by H. Lundbeck A/S,
      • Harbor Therapeutics Inc
        • Table Parkinson's Disease - Pipeline by Harbor Therapeutics Inc,
      • Heptares Therapeutics Ltd
        • Table Parkinson's Disease - Pipeline by Heptares Therapeutics Ltd,
      • Herantis Pharma Plc
        • Table Parkinson's Disease - Pipeline by Herantis Pharma Plc,
      • Hisamitsu Pharmaceutical Co Inc
        • Table Parkinson's Disease - Pipeline by Hisamitsu Pharmaceutical Co Inc,
      • Horizon Pharma Plc
        • Table Parkinson's Disease - Pipeline by Horizon Pharma Plc,
      • Huons Co Ltd
        • Table Parkinson's Disease - Pipeline by Huons Co Ltd,
      • ICB International Inc
        • Table Parkinson's Disease - Pipeline by ICB International Inc,
      • Immungenetics AG
        • Table Parkinson's Disease - Pipeline by Immungenetics AG,
      • Impel NeuroPharma Inc
        • Table Parkinson's Disease - Pipeline by Impel NeuroPharma Inc,
      • Intec Pharma ltd
        • Table Parkinson's Disease - Pipeline by Intec Pharma ltd,
      • Integrative Research Laboratories Sweden AB
        • Table Parkinson's Disease - Pipeline by Integrative Research Laboratories Sweden AB,
      • InterMed Discovery GmbH
        • Table Parkinson's Disease - Pipeline by InterMed Discovery GmbH,
      • International Stem Cell Corp
        • Table Parkinson's Disease - Pipeline by International Stem Cell Corp,
      • Io Therapeutics Inc
        • Table Parkinson's Disease - Pipeline by Io Therapeutics Inc,
      • Iproteos SL
        • Table Parkinson's Disease - Pipeline by Iproteos SL,
      • Jeil Pharmaceutical Co Ltd
        • Table Parkinson's Disease - Pipeline by Jeil Pharmaceutical Co Ltd,
      • Kainos Medicine Inc
        • Table Parkinson's Disease - Pipeline by Kainos Medicine Inc,
      • Khondrion BV
        • Table Parkinson's Disease - Pipeline by Khondrion BV,
      • KineMed Inc
        • Table Parkinson's Disease - Pipeline by KineMed Inc,
      • Kissei Pharmaceutical Co Ltd
        • Table Parkinson's Disease - Pipeline by Kissei Pharmaceutical Co Ltd,
      • Kyowa Hakko Kirin Co Ltd
        • Table Parkinson's Disease - Pipeline by Kyowa Hakko Kirin Co Ltd,
      • Lead Discovery Center GmbH
        • Table Parkinson's Disease - Pipeline by Lead Discovery Center GmbH,
      • Living Cell Technologies Ltd
        • Table Parkinson's Disease - Pipeline by Living Cell Technologies Ltd,
      • Longevity Biotech Inc
        • Table Parkinson's Disease - Pipeline by Longevity Biotech Inc,
      • Luye Pharma Group Ltd
        • Table Parkinson's Disease - Pipeline by Luye Pharma Group Ltd,
      • Lysosomal Therapeutics Inc
        • Table Parkinson's Disease - Pipeline by Lysosomal Therapeutics Inc,
      • M et P Pharma AG
        • Table Parkinson's Disease - Pipeline by M et P Pharma AG,
      • M's Science Corp
        • Table Parkinson's Disease - Pipeline by M's Science Corp,
      • M3 Biotechnology Inc
        • Table Parkinson's Disease - Pipeline by M3 Biotechnology Inc,
      • MedGenesis Therapeutix Inc
        • Table Parkinson's Disease - Pipeline by MedGenesis Therapeutix Inc,
      • MedImmune LLC
        • Table Parkinson's Disease - Pipeline by MedImmune LLC,
      • MeiraGTx Ltd
        • Table Parkinson's Disease - Pipeline by MeiraGTx Ltd,
      • Merck & Co Inc
        • Table Parkinson's Disease - Pipeline by Merck & Co Inc,
      • Metabolic Solutions Development Company LLC
        • Table Parkinson's Disease - Pipeline by Metabolic Solutions Development Company LLC,
      • Minerva Neurosciences Inc
        • Table Parkinson's Disease - Pipeline by Minerva Neurosciences Inc,
      • Mission Therapeutics Ltd
        • Table Parkinson's Disease - Pipeline by Mission Therapeutics Ltd,
      • Mitochon Pharmaceuticals Inc
        • Table Parkinson's Disease - Pipeline by Mitochon Pharmaceuticals Inc,
      • MitoDys Therapeutics Ltd
        • Table Parkinson's Disease - Pipeline by MitoDys Therapeutics Ltd,
      • Motac Neuroscience Ltd
        • Table Parkinson's Disease - Pipeline by Motac Neuroscience Ltd,
      • Netherlands Translational Research Center BV
        • Table Parkinson's Disease - Pipeline by Netherlands Translational Research Center BV,
      • Neuralstem Inc
        • Table Parkinson's Disease - Pipeline by Neuralstem Inc,
      • Neuraltus Pharmaceuticals Inc
        • Table Parkinson's Disease - Pipeline by Neuraltus Pharmaceuticals Inc,
      • Neuren Pharmaceuticals Ltd
        • Table Parkinson's Disease - Pipeline by Neuren Pharmaceuticals Ltd,
      • NeuroDerm Ltd
        • Table Parkinson's Disease - Pipeline by NeuroDerm Ltd,
      • NeuroNascent Inc
        • Table Parkinson's Disease - Pipeline by NeuroNascent Inc,
      • NeurOp Inc
        • Table Parkinson's Disease - Pipeline by NeurOp Inc,
      • Neuropore Therapies Inc
        • Table Parkinson's Disease - Pipeline by Neuropore Therapies Inc,
      • New World Laboratories Inc
        • Table Parkinson's Disease - Pipeline by New World Laboratories Inc,
      • Newron Pharmaceuticals SpA
        • Table Parkinson's Disease - Pipeline by Newron Pharmaceuticals SpA,
      • nLife Therapeutics SL
        • Table Parkinson's Disease - Pipeline by nLife Therapeutics SL,
      • NLS Pharma Group
        • Table Parkinson's Disease - Pipeline by NLS Pharma Group,
      • Novartis AG
        • Table Parkinson's Disease - Pipeline by Novartis AG,
      • Novo Nordisk A/S
        • Table Parkinson's Disease - Pipeline by Novo Nordisk A/S,
      • NsGene A/S
        • Table Parkinson's Disease - Pipeline by NsGene A/S,
      • Omeros Corp
        • Table Parkinson's Disease - Pipeline by Omeros Corp,
      • Oncodesign SA
        • Table Parkinson's Disease - Pipeline by Oncodesign SA,
      • Ono Pharmaceutical Co Ltd
        • Table Parkinson's Disease - Pipeline by Ono Pharmaceutical Co Ltd,
      • OPKO Health Inc
        • Table arkinson's Disease - Pipeline by OPKO Health Inc,
      • Orion Oyj
        • Table Parkinson's Disease - Pipeline by Orion Oyj,
      • Oryzon Genomics SA
        • Table Parkinson's Disease - Pipeline by Oryzon Genomics SA,
      • Oxford BioMedica Plc
        • Table Parkinson's Disease - Pipeline by Oxford BioMedica Plc,
      • ParkCell AB
        • Table Parkinson's Disease - Pipeline by ParkCell AB,
      • Peptron Inc
        • Table Parkinson's Disease - Pipeline by Peptron Inc,
      • Pfizer Inc
        • Table Parkinson's Disease - Pipeline by Pfizer Inc,
      • Pharma Two B Ltd
        • Table Parkinson's Disease - Pipeline by Pharma Two B Ltd,
      • PharmatrophiX Inc
        • Table Parkinson's Disease - Pipeline by PharmatrophiX Inc,
      • Pharmaxis Ltd
        • Table Parkinson's Disease - Pipeline by Pharmaxis Ltd,
      • Pharmicell Co Ltd
        • Table Parkinson's Disease - Pipeline by Pharmicell Co Ltd,
      • Pharnext SA
        • Table Parkinson's Disease - Pipeline by Pharnext SA,
      • Phenomenome Discoveries Inc
        • Table Parkinson's Disease - Pipeline by Phenomenome Discoveries Inc,
      • Plex Pharmaceuticals Inc
        • Table Parkinson's Disease - Pipeline by Plex Pharmaceuticals Inc,
      • Prana Biotechnology Ltd
        • Table Parkinson's Disease - Pipeline by Prana Biotechnology Ltd,
      • Prexton Therapeutics SA
        • Table Parkinson's Disease - Pipeline by Prexton Therapeutics SA,
      • Primary Peptides Inc
        • Table Parkinson's Disease - Pipeline by Primary Peptides Inc,
      • Proclara Biosciences Inc
        • Table Parkinson's Disease - Pipeline by Proclara Biosciences Inc,
      • Promentis Pharmaceuticals Inc
        • Table Parkinson's Disease - Pipeline by Promentis Pharmaceuticals Inc,
      • Promius Pharma LLC
        • Table Parkinson's Disease - Pipeline by Promius Pharma LLC,
      • Proteostasis Therapeutics Inc
        • Table Parkinson's Disease - Pipeline by Proteostasis Therapeutics Inc,
      • Prothena Corp Plc
        • Table Parkinson's Disease - Pipeline by Prothena Corp Plc,
      • QR Pharma Inc
        • Table Parkinson's Disease - Pipeline by QR Pharma Inc,
      • reMYND NV
        • Table Parkinson's Disease - Pipeline by reMYND NV,
      • Retrotope Inc
        • Table Parkinson's Disease - Pipeline by Retrotope Inc,
      • Sage Therapeutics Inc
        • Table Parkinson's Disease - Pipeline by Sage Therapeutics Inc,
      • Saje Pharma LLC
        • Table Parkinson's Disease - Pipeline by Saje Pharma LLC,
      • SanBio Inc
        • Table Parkinson's Disease - Pipeline by SanBio Inc,
      • Saneron CCEL Therapeutics Inc
        • Table Parkinson's Disease - Pipeline by Saneron CCEL Therapeutics Inc,
      • Saniona AB
        • Table Parkinson's Disease - Pipeline by Saniona AB,
      • Sellas Inc
        • Table Parkinson's Disease - Pipeline by Sellas Inc,
      • Serina Therapeutics Inc
        • Table Parkinson's Disease - Pipeline by Serina Therapeutics Inc,
      • Shire Plc
        • Table Parkinson's Disease - Pipeline by Shire Plc,
      • Sigma-Tau SpA
        • Table Parkinson's Disease - Pipeline by Sigma-Tau SpA,
      • SignPath Pharma Inc
        • Table Parkinson's Disease - Pipeline by SignPath Pharma Inc,
      • Signum Biosciences Inc
        • Table Parkinson's Disease - Pipeline by Signum Biosciences Inc,
      • SK Biopharmaceuticals Co Ltd
        • Table Parkinson's Disease - Pipeline by SK Biopharmaceuticals Co Ltd,
      • STATegics Inc
        • Table Parkinson's Disease - Pipeline by STATegics Inc,
      • Stelic Institute & Co Inc
        • Table Parkinson's Disease - Pipeline by Stelic Institute & Co Inc,
      • Sun Pharma Advanced Research Company Ltd
        • Table Parkinson's Disease - Pipeline by Sun Pharma Advanced Research Company Ltd,
      • Sunovion Pharmaceuticals Inc
        • Table Parkinson's Disease - Pipeline by Sunovion Pharmaceuticals Inc,
      • Synthonics Inc
        • Table Parkinson's Disease - Pipeline by Synthonics Inc,
      • Takara Bio Inc
        • Table Parkinson's Disease - Pipeline by Takara Bio Inc,
      • Takeda Pharmaceutical Company Ltd
        • Table Parkinson's Disease - Pipeline by Takeda Pharmaceutical Company Ltd,
      • TauRx Therapeutics Ltd
        • Table Parkinson's Disease - Pipeline by TauRx Therapeutics Ltd,
      • TechnoPhage SA
        • Table Parkinson's Disease - Pipeline by TechnoPhage SA,
      • Teikoku Pharma USA Inc
        • Table Parkinson's Disease - Pipeline by Teikoku Pharma USA Inc,
      • Teva Pharmaceutical Industries Ltd
        • Table Parkinson's Disease - Pipeline by Teva Pharmaceutical Industries Ltd,
      • Titan Pharmaceuticals Inc
        • Table Parkinson's Disease - Pipeline by Titan Pharmaceuticals Inc,
      • Trevena Inc
        • Table Parkinson's Disease - Pipeline by Trevena Inc,
      • TyrNovo Ltd
        • Table Parkinson's Disease - Pipeline by TyrNovo Ltd,
      • UniQure NV
        • Table Parkinson's Disease - Pipeline by UniQure NV,
      • Vanton Research Laboratory LLC
        • Table Parkinson's Disease - Pipeline by Vanton Research Laboratory LLC,
      • Varinel Inc
        • Table Parkinson's Disease - Pipeline by Varinel Inc,
      • VistaGen Therapeutics Inc
        • Table Parkinson's Disease - Pipeline by VistaGen Therapeutics Inc,
      • VivaCell Biotechnology Espana SL
        • Table Parkinson's Disease - Pipeline by VivaCell Biotechnology Espana SL,
      • Voyager Therapeutics Inc
        • Table Parkinson's Disease - Pipeline by Voyager Therapeutics Inc,
      • vTv Therapeutics Inc
        • Table Parkinson's Disease - Pipeline by vTv Therapeutics Inc,
      • Wellstat Therapeutics Corp
        • Table Parkinson's Disease - Pipeline by Wellstat Therapeutics Corp,
  • Therapeutics Assessment
    • Alzheimer's Disease
      • Assessment by Monotherapy Products
        • Table Figure 37: Assessment by Monotherapy Products, Alzheimer's Disease
        • Table Assessment by Monotherapy Products, Alzheimer's Disease
      • Assessment by Combination Products
        • Table Figure 38: Assessment by Combination Products, Alzheimer's Disease
        • Table Assessment by Combination Products, Alzheimer's Disease
      • Assessment by Target
        • Table Figure 39: Number of Products by Top 10 Targets, Alzheimer's Disease
        • Table Figure 40: Number of Products by Stage and Top 10 Targets, Alzheimer's Disease
        • Table Number of Products by Stage and Target, Alzheimer's Disease
      • Assessment by Mechanism of Action
        • Table Figure 41: Number of Products by Top 10 Mechanism of Actions, Alzheimer's Disease
        • Table Figure 42: Number of Products by Stage and Top 10 Mechanism of Actions, Alzheimer's Disease
        • Table Number of Products by Stage and Mechanism of Action, Alzheimer's Disease
      • Assessment by Route of Administration
        • Table Figure 43: Number of Products by Top 10 Routes of Administration, Alzheimer's Disease
        • Table Figure 44: Number of Products by Stage and Top 10 Routes of Administration, Alzheimer's Disease
        • Table Number of Products by Stage and Route of Administration, Alzheimer's Disease
      • Assessment by Molecule Type
        • Table Figure 45: Number of Products by Top 10 Molecule Types, Alzheimer's Disease
        • Table Figure 46: Number of Products by Stage and Top 10 Molecule Types, Alzheimer's Disease
        • Table Number of Products by Stage and Molecule Type, Alzheimer's Disease
    • Amyotrophic Lateral Sclerosis
      • Assessment by Monotherapy Products
        • Table Figure 47: Assessment by Monotherapy Products, Amyotrophic Lateral Sclerosis
        • Table Assessment by Monotherapy Products, Amyotrophic Lateral Sclerosis
      • Assessment by Combination Products
        • Table Figure 48: Assessment by Combination Products, Amyotrophic Lateral Sclerosis
        • Table Assessment by Combination Products, Amyotrophic Lateral Sclerosis
      • Assessment by Target
        • Table Figure 49: Number of Products by Top 10 Targets, Amyotrophic Lateral Sclerosis
        • Table Figure 50: Number of Products by Stage and Top 10 Targets, Amyotrophic Lateral Sclerosis
        • Table Number of Products by Stage and Target, Amyotrophic Lateral Sclerosis
      • Assessment by Mechanism of Action
        • Table Figure 51: Number of Products by Top 10 Mechanism of Actions, Amyotrophic Lateral Sclerosis
        • Table Figure 52: Number of Products by Stage and Top 10 Mechanism of Actions, Amyotrophic Lateral Sclerosis
        • Table Number of Products by Stage and Mechanism of Action, Amyotrophic Lateral Sclerosis
      • Assessment by Route of Administration
        • Table Figure 53: Number of Products by Top 10 Routes of Administration, Amyotrophic Lateral Sclerosis
        • Table Figure 54: Number of Products by Stage and Top 10 Routes of Administration, Amyotrophic Lateral Sclerosis
        • Table Number of Products by Stage and Route of Administration, Amyotrophic Lateral Sclerosis
      • Assessment by Molecule Type
        • Table Figure 55: Number of Products by Top 10 Molecule Types, Amyotrophic Lateral Sclerosis
        • Table Figure 56: Number of Products by Stage and Top 10 Molecule Types, Amyotrophic Lateral Sclerosis
        • Table Number of Products by Stage and Molecule Type, Amyotrophic Lateral Sclerosis
    • Huntington Disease
      • Assessment by Monotherapy Products
        • Table Figure 57: Assessment by Monotherapy Products, Huntington Disease
        • Table Assessment by Monotherapy Products, Huntington Disease
      • Assessment by Target
        • Table Figure 58: Number of Products by Top 10 Targets, Huntington Disease
        • Table Figure 59: Number of Products by Stage and Top 10 Targets, Huntington Disease
        • Table Number of Products by Stage and Target, Huntington Disease
      • Assessment by Mechanism of Action
        • Table Figure 60: Number of Products by Top 10 Mechanism of Actions, Huntington Disease
        • Table Figure 61: Number of Products by Stage and Top 10 Mechanism of Actions, Huntington Disease
        • Table Number of Products by Stage and Mechanism of Action, Huntington Disease
      • Assessment by Route of Administration
        • Table Figure 62: Number of Products by Top 10 Routes of Administration, Huntington Disease
        • Table Figure 63: Number of Products by Stage and Top 10 Routes of Administration, Huntington Disease
        • Table Number of Products by Stage and Route of Administration, Huntington Disease
      • Assessment by Molecule Type
        • Table Figure 64: Number of Products by Top 10 Molecule Types, Huntington Disease
        • Table Figure 65: Number of Products by Stage and Top 10 Molecule Types, Huntington Disease
        • Table Number of Products by Stage and Molecule Type, Huntington Disease
    • Multiple Sclerosis
      • Assessment by Monotherapy Products
        • Table Figure 66: Assessment by Monotherapy Products, Multiple Sclerosis
        • Table Assessment by Monotherapy Products, Multiple Sclerosis
      • Assessment by Combination Products
        • Table Assessment by Combination Products, Multiple Sclerosis
      • Assessment by Target
        • Table Figure 67: Number of Products by Top 10 Targets, Multiple Sclerosis
        • Table Figure 68: Number of Products by Stage and Top 10 Targets, Multiple Sclerosis
        • Table Number of Products by Stage and Target, Multiple Sclerosis
      • Assessment by Mechanism of Action
        • Table Figure 69: Number of Products by Top 10 Mechanism of Actions, Multiple Sclerosis
        • Table Figure 70: Number of Products by Stage and Top 10 Mechanism of Actions, Multiple Sclerosis
        • Table Number of Products by Stage and Mechanism of Action, Multiple Sclerosis
      • Assessment by Route of Administration
        • Table Figure 71: Number of Products by Top 10 Routes of Administration, Multiple Sclerosis
        • Table Figure 72: Number of Products by Stage and Top 10 Routes of Administration, Multiple Sclerosis
        • Table Number of Products by Stage and Route of Administration, Multiple Sclerosis
      • Assessment by Molecule Type
        • Table Figure 73: Number of Products by Top 10 Molecule Types, Multiple Sclerosis
        • Table Figure 74: Number of Products by Stage and Top 10 Molecule Types, Multiple Sclerosis
        • Table Number of Products by Stage and Molecule Type, Multiple Sclerosis
    • Parkinson's Disease
      • Assessment by Monotherapy Products
        • Table Figure 75: Assessment by Monotherapy Products, Parkinson's Disease
        • Table Assessment by Monotherapy Products, Parkinson's Disease
      • Assessment by Combination Products
        • Table Figure 76: Assessment by Combination Products, Parkinson's Disease
        • Table Assessment by Combination Products, Parkinson's Disease
      • Assessment by Target
        • Table Figure 77: Number of Products by Top 10 Targets, Parkinson's Disease
        • Table Figure 78: Number of Products by Stage and Top 10 Targets, Parkinson's Disease
        • Table Number of Products by Stage and Target, Parkinson's Disease
      • Assessment by Mechanism of Action
        • Table Figure 79: Number of Products by Top 10 Mechanism of Actions, Parkinson's Disease
        • Table Figure 80: Number of Products by Stage and Top 10 Mechanism of Actions, Parkinson's Disease
        • Table Number of Products by Stage and Mechanism of Action, Parkinson's Disease
      • Assessment by Route of Administration
        • Table Figure 81: Number of Products by Top 10 Routes of Administration, Parkinson's Disease
        • Table Figure 82: Number of Products by Stage and Top 10 Routes of Administration, Parkinson's Disease
        • Table Number of Products by Stage and Route of Administration, Parkinson's Disease
      • Assessment by Molecule Type
        • Table Figure 83: Number of Products by Top 10 Molecule Types, Parkinson's Disease
        • Table Figure 84: Number of Products by Stage and Top 10 Molecule Types, Parkinson's Disease
        • Table Number of Products by Stage and Molecule Type, Parkinson's Disease
  • Dormant Projects
    • Alzheimer's Disease
      • Table Alzheimer's Disease - Dormant Projects,
    • Amyotrophic Lateral Sclerosis
      • Table Amyotrophic Lateral Sclerosis - Dormant Projects,
    • Huntington Disease
      • Table Huntington Disease - Dormant Projects,
    • Multiple Sclerosis
      • Table Multiple Sclerosis - Dormant Projects,
    • Parkinson's Disease
      • Table Parkinson's Disease - Dormant Projects,
  • Discontinued Products
    • Alzheimer's Disease
      • Table Alzheimer's Disease - Discontinued Products,
    • Amyotrophic Lateral Sclerosis
      • Table Amyotrophic Lateral Sclerosis - Discontinued Products,
    • Huntington Disease
      • Table Huntington Disease - Discontinued Products,
    • Multiple Sclerosis
      • Table Multiple Sclerosis - Discontinued Products,
    • Parkinson's Disease
      • Table Parkinson's Disease - Discontinued Products,
  • Product Development Milestones
    • Alzheimer's Disease
      • Featured News & Press Releases
      • Aug 01, 2016: The results of phase I clinical trial of the Araclon Biotech Alzheimer's vaccine supports its continuation
      • Jul 29, 2016: Anavex Confirms Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer's Patients Presented at AAIC 2016
      • Jul 27, 2016: Anavex Presents 31-Week Efficacy Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer's Patients at AAIC 2016
      • Jul 27, 2016: vTv Therapeutics Announces Presentation of Phase 2b Azeliragon Results at the 2016 Alzheimer'sAssociation International Conference
      • Jul 27, 2016: Oryzon Initiates Multiple Ascending Dose Cohorts in ORY-2001 Phase 1 Clinical Trial
      • Jul 27, 2016: Stemedica Begins First Clinical Trials In The U.S. Using Adult Allogeneic Stem Cells To Treat Alzheimer Disease
      • Jul 27, 2016: TauRx Reports First Phase 3 Results for LMTX
      • Jul 27, 2016: Actinogen Medical Announces Landmark Research on Excess Cortisol and Alzheimer's disease
      • Jul 25, 2016: Alzheon Presents Positive Results of ALZ-801 Clinical Studies that Lead to Advancement to Pivotal Phase 3 Study in Alzheimer Patients with APOE4/4 Homozygous Genotype
      • Jul 24, 2016: Anavex Presents 31-Week Safety Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer's Patients at AAIC 2016
      • Jul 20, 2016: Corium to Present Clinical Data from a Phase 1 Pharmacokinetic Study of Once-Weekly Corplex Donepezil Transdermal System
      • Jul 14, 2016: vTv Therapeutics Announces Phase 2b Azeliragon Data Selected for Oral Presentation at the 2016 Alzheimer's Association International Conference
      • Jul 14, 2016: ProMIS Neurosciences announces new program to identify novel Alzheimer's disease targets on toxic strains of protein tau
      • Jul 13, 2016: IntelGenx to Initiate Phase 1 Trial of Montelukast
    • Amyotrophic Lateral Sclerosis
      • Featured News & Press Releases
      • Nov 17, 2016: Catabasis Pharmaceuticals Provides Update on Rare Disease Program CAT-4001 at Investor Day
      • Nov 10, 2016: MediciNova Announces European Medicines Agency Recommends Orphan Medicinal Product Designation for MN-166 (ibudilast) for Amyotrophic Lateral Sclerosis
      • Oct 30, 2016: MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 27th International Symposium on ALS/MND in Dublin, Ireland
      • Oct 20, 2016: Cedars-Sinai Receives Approval to Test Novel Combined Stem Cell and Gene Therapy for ALS Patients
      • Oct 18, 2016: Cytokinetics Announces First Patient Enrolled in VIGOR-ALS, an Open-Label Extension Clinical Trial of Tirasemtiv
      • Oct 13, 2016: Flex Pharma Provides FLX-787 Nocturnal Leg Cramp Regulatory and Clinical Update
      • Oct 11, 2016: MeiraGTx Expands ALS Gene Therapy Program in Collaboration with Weill Cornell Medicine and LSU
      • Oct 11, 2016: MediciNova Announces FDA Granted Orphan Drug Designation to MN-166 (ibudilast) for Amyotrophic Lateral Sclerosis
      • Oct 03, 2016: AB Science has been invited at four international meetings to present new preclinical data showing neuroprotective effect of masitinib in amyotrophic lateral sclerosis (ALS)
      • Sep 29, 2016: AB Science Announces the Filing of Masitinib in the Treatment of Amyotrophic Lateral Sclerosis (ALS) to the European Medicines Agency
      • Sep 22, 2016: Neuraltus Pharmaceuticals Initiates Confirmatory Phase 2 Study of NP001 in Patients with Amyotrophic Lateral Sclerosis
      • Sep 13, 2016: Flex Pharma Initiates Phase 2 Efficacy Study in Amyotrophic Lateral Sclerosis
      • Aug 31, 2016: ACTEMRA Subcutaneous Injection Wins a Prize at the JAPAN PACKAGING CONTEST 2016
      • Aug 30, 2016: FDA Accepts Mitsubishi Tanabe Pharma's NDA Filing for Edaravone to Treat ALS
    • Huntington Disease
      • Featured News & Press Releases
      • Sep 19, 2016: Teva Announces Results from Exploratory 52-Week Phase 2 PRIDE-HD Study of Pridopidine in Huntington Disease
      • Sep 09, 2016: Vaccinex Announces Continuation of the SIGNAL Clinical Trial
      • Aug 24, 2016: Novel Gene Therapy Drug for Huntington Disease
      • Aug 23, 2016: Vaccinex Receives Orphan Drug Designation from U.S. FDA for its Lead Antibody Product Candidate, VX15, as a Potential Treatment for Huntington Disease
      • Aug 01, 2016: Vaccinex Receives FDA Fast Track Designation for VX15 Antibody for the Treatment of Huntington's Disease
      • Jul 05, 2016: Teva and the Huntington Study Group Announce Publication of Pivotal Phase III Data on Deutetrabenazine (SD-809) in Huntington Disease from First-HD Trial in JAMA
      • Jun 21, 2016: WAVE Life Sciences Receives Orphan Drug Designation from FDA for its Lead Candidate Designed to Treat Huntington Disease
      • May 31, 2016: Teva Receives Complete Response Letter for NDA for SD-809 for the Treatment of Chorea Associated with Huntington Disease
      • May 17, 2016: Mitochon Pharmaceuticals Raises $1.6M for Clinical Stage Development
      • Apr 18, 2016: Teva Presents New Data for SD-809 in Huntington Disease at 68th American Academy of Neurology Annual Meeting in Vancouver, B.C.
      • Apr 12, 2016: Teva to Present Data on SD-809 (deutetrabenazine) at 68th AAN Annual Meeting
      • Mar 22, 2016: uniQure Announces Preclinical Proof of Concept for Gene Therapy Approach in Huntington Disease
      • Jan 11, 2016: Active Biotech: Information regarding the clinical study LEGATO-HD
      • Jan 04, 2016: Vaccinex Inc. Completes Enrollment of Cohort A in its SIGNAL Clinical Trial, a Randomized Phase 2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of VX15/2503 in Subjects at Risk for or with Early Signs of Huntington Disease
    • Multiple Sclerosis
      • Featured News & Press Releases
      • Dec 09, 2016: Biogen and AbbVie Receive Health Canada Approval of Once-Monthly ZINBRYTA (Daclizumab Beta) for Multiple Sclerosis
      • Dec 09, 2016: Biogen and AbbVie Receive Health Canada Approval of Once-Monthly ZINBRYTA (Daclizumab Beta) for Multiple Sclerosis
      • Dec 07, 2016: GeNeuro and Servier announce ANGEL-MS extension clinical study in multiple sclerosis
      • Nov 07, 2016: Innate Immunotherapeutics reports very strong interest from patients wanting access to drug post-trial completion
      • Nov 04, 2016: ATL1102 for Multiple Sclerosis - Progress Update
      • Nov 02, 2016: Opexa Announces Reduction in Workforce in Light of Top-Line Results from Phase 2b Abili-T Trial of Tcelna (imilecleucel-T) in Secondary Progressive Multiple Sclerosis
      • Oct 28, 2016: Opexa Therapeutics Announces Phase 2b Abili-T Trial of Tcelna (imilecleucel-T) in Secondary Progressive Multiple Sclerosis Did Not Meet Primary Endpoint
      • Oct 27, 2016: GNS Healthcare to Present Innovative Efficacy to Real-World Effectiveness Solution at ISPOR Europe
      • Oct 18, 2016: RedHill Biopharma Announces Allowance of a Patent in Japan Supporting RHB-104 for Multiple Sclerosis
      • Oct 13, 2016: Flex Pharma Provides FLX-787 Nocturnal Leg Cramp Regulatory and Clinical Update
      • Oct 06, 2016: RedHill Biopharma Provides Progress Update on RHB-104 Phase III Crohn's Disease Program and Introduces Option for Early Stop for Success in Q2/2017
      • Sep 29, 2016: Actelion To Investigate All-Oral Combination Therapy For Patients With Relapsing Multiple Sclerosis
      • Sep 28, 2016: Anavex Compound to be Tested in Biogen Neurological Protection Model
    • Parkinson's Disease
      • Featured News & Press Releases
      • Dec 13, 2016: Kyowa Hakko Kirin Announces Top-Line Results of Global Phase 3 Trial of KW-6002 (Istradefylline) for Parkinsons Disease
      • Dec 13, 2016: First-In-Human Assessment of PRX002, Prothenas Anti-Alpha Synuclein Antibody for Parkinsons Disease, Published in Movement Disorders Journal
      • Dec 13, 2016: Sage Therapeutics Announces Initiation of Phase 2 Clinical Development for SAGE-217 in Movement Disorders
      • Dec 12, 2016: Herantis Pharmas Parkinson study wins EUR 6.0 million grant from the European Union Horizon 2020 program
      • Dec 08, 2016: MRI Interventions' ClearPoint Neuro Navigation System Utilized in Voyager Therapeutics' VY-AADC01 Phase 1b Trial; Positive Interim Results Reported
      • Dec 07, 2016: International Stem Cell Announces Second Patient with Parkinsons Disease Treated in Phase I Clinical Trial
      • Dec 07, 2016: Diabetes drug slows experimental Parkinsons disease progression, human trials to begin next year
      • Dec 07, 2016: Voyager Therapeutics Announces Positive Interim Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinsons Disease
      • Dec 05, 2016: NeuroDerm to Replace Two Phase 3 Clinical Trials with Small Pharmacokinetic Trials Following FDA Meeting on ND0612 Regulatory Development
      • Dec 02, 2016: NeuroDerm Announces Top-Line Results of Pilot PK Trial Comparing ND0701 with Commercial Apomorphine
      • Dec 01, 2016: Agilis Biotherapeutics Announces Orphan Designation Approval in Europe for the Treatment of AADC Deficiency
      • Nov 28, 2016: Intec Pharma Enters into Agreement with the Michael J. Fox Foundation Around Its Phase III Trial Recruitment
      • Nov 09, 2016: Intec Pharma to Sponsor Investigator Meeting for Pivotal Phase III Study of Accordion Pill Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
      • Nov 09, 2016: Prothena Reports Results from Phase 1b Study of PRX002 Demonstrating Robust Antibody CNS Penetration and Significant Reduction of Free Serum Alpha-synuclein in Patients with Parkinson's Disease
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report